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Abstract
Liver cancers are increasingly common and require improved treatment meth-
ods. Radioembolization inhibits tumor growth by inserting small spheres into
the hepatic artery that are carried into smaller vessels near tumors, where
they deposit radiation. Predicting toxicity for this treatment is challenging
due to the microanatomical liver structure and the tendency of microspheres
to cluster when trapped.
This work describes and validates a novel method to generate personalized
hepatic arterial tree models and simulate realistic glass microsphere distribu-
tions. It describes methods to generate realistic arterial trees using physically
constrained macrocell growth models that can incorporate measurable param-
eters such as initial and terminal vessel diameters and blood pressure. It also
describes models of microsphere infusion that simulate different embolic ef-
fects and trapping behavior. Microsphere cluster-size histograms and images
at PET resolution were simulated for several infusion methods in a hepatic ar-
terial tree model generated from liver and proper hepatic artery segmentations
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taken from the XCAT phantom.
To verify the distributions created through microsphere infusion simula-
tion, a characterization of the three-dimensional clustering of glass microspheres
in tissue was necessary. However, traditional methods to find microsphere lo-
cations requires creating thin slices of treated tissue that are stained and ex-
amined microscopically, which is a very time-consuming process. This thesis
describes how to use micro-CT and image processing to detect glass micro-
spheres in whole tissue samples. The detection method was verified by pro-
cessing phantoms composed of glass microspheres embedded in agar that could
also be imaged microscopically to determine true microsphere locations. Using
this, >93% of microspheres in the phantom were correctly detected and the
percentage of erroneously detected microspheres was <5%. The mean absolute
error between the true and estimated dose maps was 4.2%.
The detection method was then applied to a treated porcine liver sample
to characterize microsphere clustering behavior in normal liver tissue. A his-
togram of these cluster sizes was compared with histograms simulated using
the tree and transport models. The most realistic clustering behavior was pro-
duced by having microspheres trap in vessels when their diameters exceeded
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Liver cancer is one of the most fatal and rapidly increasing forms of cancer
[1–3], with 400,000 new cases diagnosed each year in the US and an even
higher incidence rate in other countries [4, 5]. The liver is also a common site
for metastatic cancer growth [6]. Because of this, there is interest in improving
patient treatment and outcomes. One form of treatment is radioembolization
(RE), a minimally-invasive form of targeted treatment that uses a catheter to
deliver radioactive particles within the hepatic arterial tree. Those particles
embed in the liver near tumors, reduce blood flow in trapping vessels, and
deliver very high radiation doses that damage nearby cells and tissues [7].
The doses absorbed using RE far exceed what is possible using external
beam radiation therapy (EBRT) without inducing liver toxicity [8]. Absorbed
1
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dose from EBRT is deposited uniformly in tissues the beam passes through,
while the clustered distribution of microspheres inserted trans-arterially de-
posits a very heterogeneous dose [9]. This, together with the higher chance
of microspheres trapping near tumors and the unique structure of liver mi-
croanatomy, is thought to spare normal liver tissue [10,11].
The best patient outcomes occur when tumors receive the highest doses [12]
and sufficient normal liver tissue remains functional to compensate for tissue
that has been damaged by disease or radiation. Treatment plans specify the
administered activity, typically based on quantitative imaging of the patient,
to achieve these outcomes.
However, predicting the dose to tumors for a particular administered activ-
ity is recognized as very challenging [13]. In addition, the toxic dose for tumors
is typically more variable than for normal tissue due to the heterogeneity of
liver tumor cells. Because of this, it has been argued that delivering the high-
est safe dose to normal liver tissue will also provide the highest dose to tumor
tissues and increase the probability of tumor control [14]. The mechanism by
which normal liver tissue survives the high absorbed doses delivered by RE
is incompletely understood, which limits the accuracy of predictions of normal




Previous studies have attempted to understand the absorbed dose tolerance of
normal liver tissues by modeling the hepatic arterial tree (HAT) and simulat-
ing microsphere infusions and trapping [10]. However, the predicted micro-
sphere cluster distributions from those simulations have not been verified in
vivo, and the structure of the HAT models had some aspects that were phys-
ically unrealistic [15]. The ability to model personalized, physically realistic
HATs suitable for microsphere infusion simulation could allow different treat-
ment plans to be compared and the resulting small-scale dose distributions to
be analyzed.
Better treatment planning methods could be developed if the non-uniform
doses due to microsphere clustering and the effects on liver tissue were better
understood.
In order to verify that the clusters produced using a physically realistic
model of the HAT are clinically relevant, simulated cluster properties must be
compared to true clusters. While it is possible to perform ex-vivo tissue analysis
to characterize microsphere distributions in treated tissues, current methods
are manual and very time-consuming and make 3D cluster characterization
difficult. Accordingly, previous analyses of microsphere clusters have only ex-
amined small areas of tissue, potentially underestimating cluster extents. The
3
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ability to detect 3D microsphere locations in larger tissue blocks could provide
a better understanding of the quantity and variety of microsphere clusters in
normal liver tissue.
With a better understanding of the microsphere clusters and dose distri-
butions, it could be possible to better predict the effect of different treatment
plans on normal liver tissue and thus improve patient outcomes.
The ability to create a personalized computational model of the hepatic ar-
terial tree and simulate the administration of different total and specific activ-
ities could be a useful tool for doctors to optimize treatment plans.
1.2 Organization
This dissertation first explains background information necessary to under-
stand the research undertaken in support of the thesis. Following that are
chapters describing novel work to improve treatment planning tools. Those
chapters have either been published, submitted for peer review, or are being
prepared for publication.
Chapter 2 reviews the properties of the liver that make it a common site
for primary and metastatic cancers, and a challenging target for other cancer
treatments. The chapter also describes the unique anatomical features of the
liver and related cancers that make RE a viable treatment strategy, and briefly
explains the relevant physics and biological impacts of radiation-based treat-
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ment methods. The basic features of the two FDA-approved RE devices are
summarized. Information relevant to micro-computed tomography (CT) imag-
ing of small, highly attenuating objects (such as glass microspheres containing
yttrium) is also presented with important details from previous work detecting
microspheres at the scale of a few dozen microns.
Chapter 3 describes initial work to develop a model of the hepatic arterial
tree that is both physically realistic and sufficiently detailed to allow particle
infusion modeling. It shows simulated dose maps that are qualitatively similar
to those observed in patient dose maps created using PET imaging.
Chapter 4 explains how 3D glass microsphere locations can be estimated in
reasonably large tissue samples using micro-CT and standard morphological
image processing algorithms without requiring the tedious specimen slicing,
staining, and scanning most commonly used to investigate microsphere local-
ization.
Chapter 5 shows how glass microspheres cluster in normal porcine livers
using the microsphere location estimation algorithm. It then describes how the
particle transport and trapping model from chapter 3 was adapted to produce
clusters similar to those measured in the normal porcine livers.
Chapter 6 reviews the novel findings of this work and suggests potential




In order to provide context for the work undertaken for this thesis, this chapter
describes relevant background concepts.This work focuses on radioemboliza-
tion of liver cancer, and thus an understanding of the anatomical and physio-
logical properties of the liver is beneficial. Thus, the basic function and form
of the liver are summarized. A brief discussion of the pathology and treatment
of liver cancers is undertaken prior to the introduction of RE as a promising
therapy. The biological effects of both embolization and radiation are reviewed,
with particular attention paid to the interactions of radiation with tissue from
the scale of individual atoms to the full liver.
Comparisons between the maximum tolerable absorbed dose (MTAD) of
normal liver tissue treated with RE and more uniform absorbed dose deliv-
6
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ery methods suggests that spatial clustering of microspheres is relevant to
predicting the biological impact of RE treatments. Due to the composition
of microspheres used for some RE treatments and the inadequacy of current
methods for analyses of microsphere clustering in large tissue samples, micro-
CT imaging of tissue with embedded microspheres is suggested as a faster and
simpler microsphere detection method. Therefore, a discussion of CT imaging
procedures and properties that are relevant to the proposed use case is also
provided.
2.1 Liver anatomy
A major focus of this dissertation is radioembolization of liver cancer. This
refers to the delivery of microspheres through the hepatic vasculature to their
eventual trapping locations in the liver. Unique characteristics of the liver and
the liver vasculature determine where they are trapped. How radiation from
the decaying radionuclides in the microspheres is absorbed in the liver tissues
determines the liver toxicity. It is thus important to have some understanding
of liver anatomy and vasculature
The liver fulfills many functions within the body, from synthesizing glyco-
gen, blood proteins, and vitamins to removing dead or damaged cells and tox-
ins [16]. It also acts as a blood reservoir, able to store or supply excess blood
in response to changes in blood pressure due to the liver’s highly capacitive,
7
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heavily perfused cells [17]. The liver is unique among the visceral organs in
that it has a dual blood supply. It receives highly oxygenated blood from the
hepatic artery (HA) and nutrient-rich blood from the portal vein (PV), and the
flow from both vessel trees exits via the hepatic vein. Nearly 80% of hepatic
blood comes from the portal vein, while the remaining 20% is supplied by the
hepatic artery [18].
The liver can be divided into 8 Couinaud segments, which are defined as
portions of the liver perfused by different branches of the PV [19]. Typically,
the HA branches similarly [20]. As the PV ramifies down to the level of the
smallest venules, the HA branches into hepatic arterioles. At the lowest level,
the portal venules and terminal hepatic arterioles (THAs) form portal tracts
that perfuse the smallest functional units of the liver.
Each portal tract receives blood from THAs or portal venules, usually both
[21]. The blood flows away through three sinusoids, which are a type of capil-
lary with a specialized lumen (vessel lining) that allows the blood-borne molecules
to enter and exit nearby parenchymal cells. Those cells include Kupffer cells,
which are macrophages that destroy damaged cells and rid the body of toxins,
and hepatocytes, which process nutrients carried by the portal venous system
from the stomach and intestines into glycogen and synthesize necessary vita-
mins. The blood then drains into the centrilobular vein that terminates each
sinusoid. The centrilobular veins merge into the hepatic vein and join the infe-
8
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rior vena cava, which connects to the right atrium of the heart [18].
There are two ways to interpret the smallest functional units of the liver:
the lobule model and the acinus model, depicted in figure 2.1. Lobules are
approximately shaped as hexagonal prisms with a portal tract at each corner
of the hexagon and a centrilobular vein at the center.
The acinus model is similar to the lobule model, except it is centered on the
portal tracts and better reflects the metabolic zonation of the sub-units [22]. In
this work, the THA-centered acinus model is used as it is a more convenient
model of the HA structure.
Each acinus operates in parallel with the other acinii, which means that
regular hepatic function can continue even with partial liver damage [11]. The
liver can also regenerate to replace resected cells, though liver function can
be compromised in cases where patients have existing liver diseases such as
cirrhosis [23].
Due to the liver’s role in removing damaged cells and filtering toxic sub-
stances from the blood [22], it is commonly involved in both primary cancers
arising from damage to liver tissues and metastatic cancers from circulating
cancer cells [6]. Patients without cirrhosis presenting with a single, accessible
lesion are candidates for resection, or surgical tumor removal [24]. Liver trans-
plantation can be employed if the patient has less than 4 small lesions, though
the availability of donor livers prevents this from being used as commonly
9
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Figure 2.1: Liver microanatomy. The black hexagon represents a lobule, while
the red triangle represents an acinus. In this simplified depiction, each cor-
ner of the hexagon coincides with a portal triad. Portal triads contain portal
venules, hepatic arterioles, and bile ductules. In most portal triads, there are
more than one terminal arteriole, and sometimes portal venules or hepatic ar-
terioles are not present.
as would otherwise be indicated. Unresectable cancers can also be treated
with radio-frequency ablation [24]. Other therapies, such as RE (discussed
below) are considered palliative, not curative. However, some palliative thera-






Cancers that have developed in or metastasized to the liver receive a majority
of flow from the highly oxygenated hepatic arterial blood [19]. This tumoral
preference for arterial blood also suggests a form of treatment that interrupts
the supply of arterial blood to tumors by injecting particles into the arterial
flow that trap in the smallest vessels at or near the tumors. The smallest hep-
atic arterioles have an average diameter of 11.8 µm, so the spherical particles
intended to trap in such vessels are sized at a couple dozen µm in diameter.
These spheres are known as microspheres. Embolizing the smallest branches
of the HAT reduces the supply of blood to tumors perfused by it, while nor-
mal tissue is able to survive on just the portal-venous flow and the remaining
arterial flow.
In addition to depriving tumors of oxygen-rich blood, microspheres used
for embolization are often labeled to deliver therapeutic agents to the cancer.
For example, in trans-arterial chemoembolization (TACE), the microspheres
contain chemotherapeutic agents that are eluted by the blood, thus deliver-
ing cancer-fighting drugs selectively to the tumors. [24–26]. Of interest in this
work is that the microspheres may also contain radioactive nuclei. When these
11
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nuclei decay they deposit energy in neighboring tissues, compounding the phys-
ical effects of embolization. [12].
2.2.2 Radiation
Radiation damages tissue in different ways depending on the radiation type
and energy. Ionizing radiation is radiation that can cause electrons to be
ejected from atoms and thus disrupt chemical bonds and molecular structures.
The three types of ionizing radiation most relevant to this work are beta parti-
cles, gamma rays, and x-rays. This introduction will ignore non-ionizing inter-
actions of radiation and matter.
Beta particles are charged particles that are produced by radioactive nuclei
during beta decay [27]. A β− particle is an electron, and therefore negatively
charged. The most common β− particle interaction that is of interest here is for
a β− particle to transfer energy to atoms in the object via collisional transfer.
This transfers energy from the particle to either the full atom in the form of
kinetic energy, or to an orbital electron, which either moves to a higher energy
orbital or, if sufficient energy is imparted to overcome the binding energy of
the atom, the electron is ejected and the atom is ionized [27]. Another common
occurrence, depending on the particle energy and surrounding medium, is that
the β− particle is deflected by the nucleus of the atom; the momentum lost
in this deflection is emitted as bremsstrahlung, or braking, radiation. The
12
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larger the angle of deflection, the higher the energy of the emitted photon.
While bremsstrahlung interactions do not directly ionize matter, the photons
produced by it can. This is also true of the photons emitted when electrons in
higher orbitals return to their ground state.
The other type of charged particle of interest to this work is the β+ particle,
which is a positron created by beta decay. These travel through matter, los-
ing energy, and, when almost at rest, annihilate by interaction with electrons.
The annihilation results in the emission of two 511 keV photons traveling in ap-
proximately opposite directions [28]. If the β+ particle interacts with a bound
electron, annihilation directly ionizes that atom. The 511 keV photons produced
can also ionize further matter, through photon-matter interactions discussed
below.
Gamma rays are photons emitted from a nucleus during radioactive decay,
while x-rays originate from atomic electrons [27]. Regardless of the point of
origin, these photons can directly or indirectly ionize matter through the pho-
toelectric effect, Compton scattering, or pair production. The particular inter-
action depends on both the incident photon energy and the composition of the
participating medium.
While Compton scattering is more common in tissue at energies used for
x-ray scans, because all incident photon energy is absorbed in the photoelectric
effect, photoelectric interactions are still a substantial cause of ionizations [27].
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Depictions of these interactions are shown in figure 2.2. Photons and free elec-
trons produced in these interactions may continue to further ionize other atoms
in secondary interactions. Further, when orbital electrons are ejected and re-
placed with other bound electrons, another photon is emitted, which may re-
sult in additional ionizations. The likelihood of a photon being absorbed or
scattered by material in its path depends on the energy of the photon and the
composition and density of the material. Photons are much more likely to in-
teract with materials having nuclei with larger numbers of protons (referred
to as higher-Z materials). A photon beam traversing matter that absorbs some
fraction of the incident photons is referred to as an attenuated beam [28].
The different radiation interactions that can ionize matter are depicted in
figure 2.2.
The amount of energy deposited into a given mass of tissue by any of these
interactions is referred to as the absorbed dose, which has units of Gray (Gy),
a derived unit equal to J/kg. The higher the absorbed dose in a volume of
tissue, the greater the chance of biological effects, such as radiation damaging
the cell structures or DNA. Different forms of ionizing radiation have different
biological effects depending on how much energy they deposit per unit distance,
referred to as the linear energy transfer (LET). Beta particles have relatively
low LET and thus require many ionizations to kill cells [29].


















Figure 2.2: Relevant ionizing interactions of radiation with matter. The top
row shows interactions of charged particles with matter and the bottom row
shows interactions of photons with matter. (a) An incoming beta particle trans-
fers energy to free a bound electron. (b) A β− particle passing near a nucleus
can have its trajectory affected and emit an x-ray whose energy depends on
the amount of deflection. (c) A β+ particle can collide with an opposite-charged
particle and annihilate, converting the particles’ mass into two 511 keV photons
traveling in opposite directions. (d) A photon impact that transfers sufficient
energy to a bound electron will eject the electron and adjust the photon tra-
jectory. (e) A photon is completely absorbed by an orbital electron and the
electron is ejected. (f) When a very high-energy photon approaches a nucleus,
it can convert into an electron-positron pair that cause further ionizations in
the manners described above.
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its decay results in energy deposition in tissues near microsphere trapping lo-
cations. 90Y is a radioactive isotope of yttrium with a half-life of 64.1 hours
that emits a β− particle while transitioning to stable 90Z. 90Y has a peak beta
particle energy of 2.28 MeV and an average energy of 0.937 MeV [19]. The max-
imum distance an 90Y beta particle travels in tissue is about 11 mm and the
average distance is about 4.1 mm [12]. Ninety percent of the energy emitted by
90Y is deposited within 5.3 mm [19], which means that trapped microspheres
emitting radiation damage nearby tissues while sparing tissues that are far-
ther away [19]. The activity of a sample of a radionuclide is measured in
disintegrations-per-second, or Becquerels (Bq) and refers to how frequently
a disintegration occurs based on the radionuclide quantity and half-life. A
radionuclide with a short half-life deposits more energy more quickly than a
radionuclide emitting the same radiation with a longer half-life.
2.2.3 Microsphere types
In the US, two types of microspheres are used to treat different liver cancers,
SIR-Spheres (SIRTEX Medical Limited) and TheraSphere (Biocompatibles UK
Limited).
SIR-Spheres are polymer-resin microspheres with an average diameter of
32 µm that are labeled with 90Y. SIR-Spheres have an activity of 50 Bq each at
calibration time and must be used within 24 hours of that time. There are sev-
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eral suggested methods for calculating the correct administered activity that
consider the liver volume, tumor burden, and more. SIR-Sphere treatment ad-
ministration is an extended process where some microspheres are delivered to
the HA, the arterial system is checked for stasis (a state where microspheres
will no longer flow through the HA), and then more spheres are administered if
stasis has not been reached. The low activity per SIR-Sphere means that tens
of millions of microspheres are necessary to provide sufficient absorbed dose to
targeted tumors.
TheraSphere are microspheres composed of glass doped with 90Y and have
a slightly smaller average diameter of 25 µm. The activity per TheraSphere is
substantially higher, at 2500 Bq per sphere. This higher activity means that
fewer microspheres are necessary to achieve a high absorbed dose of radia-
tion. Manufacturer-recommended treatment plans consider only the mass of
the treated liver volume when determining the administered activity. Also, in
contrast to SIR-Spheres, TheraSphere treatments are typically allowed to de-
cay until the manufacturer-supplied quantity of microspheres has the desired
activity and is then injected in a single bolus [19]. Both types of microspheres
are bio-compatible, but not biodegradable, meaning that they trap permanently




2.2.4 Microsphere-based tissue damage
After microspheres trap in small vessels, the emitted beta particles deposit en-
ergy into nearby tissues [30]. They damage cells in two ways: first by directly
damaging a cell’s DNA or other sensitive structures [31], and second by ioniz-
ing molecules in cells (such as water) to create free-radicals that in turn dam-
age DNA, membranes, and other cellular structures [32]. Cells usually have
mechanisms to repair sub-lethal damage, but the typically fast proliferation
of tumor cells can actually decrease their ability to tolerate radiation-induced
damage compared with normal cells [32], increasing the effectiveness of radia-
tion treatments.
A common concern when using 90Y-labeled microspheres is that a hazardous
number of microspheres could pass through the hepatic artery into the hepatic
venous system without trapping in the smallest liver vessels. This can hap-
pen due to variations in vascular morphology or shunting caused by erratically
grown tumor-supplying vessels. Spheres that pass through the liver will con-
tinue circulating through the vascular system and embed in the lungs, which
are more radio-sensitive than the liver [33], potentially resulting in radiation
pneumonitis [12, 33]. The concern about lung damage is sufficiently serious
that TheraSphere-based treatment plans call for pre-therapy measurement of
lung shunting using macroaggregated albumin (MAA), a protein-based par-
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ticle, that is labeled with 99mTc, a radionuclide that emits gamma rays with
ideal properties for nuclide medicine imaging. Like microspheres, MAA is ad-
ministered trans-arterially and mostly traps in the liver. The accompanying
technetium emits photons that can be detected to show where the MAA has
trapped. If high levels of MAA are detected in the lungs, the total adminis-
tered dose is either reduced or the treatment plan is altered to avoid serious
effects due to radiation damage in the lungs [19]. The trapped albumin parti-
cles erode after a few hours and are excreted [19].
While MAA particles are similar in size to TheraSphere and SIR-Spheres
and have been suggested as a therapy planning tool [9, 13, 34], they are not
ideal surrogates for those microspheres due to differences in observed particle
distributions [35]. This is thought to be caused by differences in particle size,
shape, and density [19], as well as frequent differences in catheter placement
during infusion [36].
Other hepatic treatments involving external sources of radiation have been
studied, such as EBRT, where one or more poly-energetic x-ray beams are fo-
cused on a tumor site [37]. The treatments are often administered over several
sessions to reduce the chance of toxicity [38], as a decreased dose rate results in
less tissue toxicity due to normal cells’ ability to repair sub-lethal damage when
compared with tumor cells [29, 37]. However, the average MTAD for EBRT is
still much lower than what is possible using RE [10, 37]. This is likely due to
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the uniform deposition of dose in EBRT [8], the tendency of microspheres to
aggregate into clusters [9], and the structure of the liver microanatomy [11].
Currently, trans-arterial treatments such as RE, TACE, and trans-arterial
embolization (TAE) are considered palliative, not curative. However, RE has
been used to downstage liver tumors and enable the use of curative options
such as resection and increase patient survival [39–41].
Optimal RE treatment plans maximize the absorbed dose in tumor tissues
without inducing toxicity in normal liver or other adjacent tissues. Such plans
maximize the probability of tumor control and may enable curative treatments.
Understanding the distribution of microspheres is important in creating opti-
mal treatment plans, as that can predict useful measures such as mean tumor
dose and the probability of normal liver toxicity. However, current technologies
for estimating microsphere quantities and locations, e.g., using SPECT or PET
imaging, are not sufficient to capture the dose heterogeneity with sufficient
resolution to predict normal tissue toxicities.
2.3 Microsphere detection
Because sufficiently accurate in-vivo detection of microsphere distributions us-
ing SPECT or PET imaging is not possible, the ability to examine tissue ex-vivo
can still yield important information about dose gradients and tumor control.
Traditional methods of sample preparation involve embedding a small tissue
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sample in paraffin, dividing the sample into thin slices a few micrometers thick,
staining the slice with a dye to increase visual contrast, and then scanning each
slice via optical microscopy and recording the locations of microspheres [42].
This is repeated for all slices. Sample slice thickness and microsphere thick-
ness must be considered when determining microsphere locations in the direc-
tion normal to the slice plane to prevent severed portions of resin spheres from
being counted in multiple sections [43]. Glass microspheres are not severed
using typical microtome-based slicing methods, but they can be pushed out of
a sample if the slices are too thin. However, slices that are too thick will not
capture the 3D microsphere locations with uniform fidelity. Due to the very
labor- and time-intensive process of slicing, staining, sectioning, scanning, and
scrutinizing samples, this method is only applied to small tissue regions. A
more useful method to examine full microsphere distributions would be able to
image whole tissue samples without requiring so much sample preparation.
2.3.1 CT image formation
CT image acquisition and reconstruction creates a three-dimensional repre-
sentation of objects being scanned using their different attenuation properties.
The fundamental basis of CT is shared with x-ray imaging. A fan- or cone-
shaped beam of x-rays passes through a 3D object and is measured at the far
side of the object at fixed intervals by a two-dimensional x-ray detector, de-
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picted in figure 2.3. As the photons pass through the object, some are scattered
and some are absorbed. The intensity is measured at each detector location and
the same set of measurements is taken from several different angles around
the imaged object. Each set of measurements is known as a projection, and a
large set of projections can be used to estimate the attenuation values within
the object.
An expression for the intensity of the x-ray beam on a point of the detector












where x and y are the coordinates of the point on the detector, S0 is the energy
spectrum of the incident x-rays, Emax is the maximum energy of that spectrum,
r(x,y) is the length of the line between the x-ray source and detector location
(x,y), and µ describes the fraction of x-rays expected to be attenuated at each
point in the 3D object. The integral along the ray between the source and
detector location (x,y) projects the attenuation values along that ray.
Equation (2.1) captures the fact that x-rays emitted from traditional sources
will have a spectrum of energies, not just one, and that different materials will
attenuate differently depending on the incident photon energy. However, due






Figure 2.3: A simplified model of a 2D CT scanner with fan-beam geometry.
The source and detector are on opposite sides of the sample being imaged; an
x-ray projection is recorded, and the source and detector are rotated and pro-
jections are acquired at a set of projection views, usually taken at small, evenly
spaced angles. The angle between projections is exaggerated here for clarity.
assumption that the source is emitting a mono-energetic beam at an energy
that will produce the same measured intensity as the actual poly-energetic
beam [27]. This yields the equation








where I0 replaces S0 as the intensity of the beam at energy Ē and d is the length
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of the line between the source and point (x,y).
The goal of CT reconstruction is to estimate µ(·) using multiple projections
taken from different angles around the body. If I0 is known, the attenuation
of all material between the source and the point (x,y) can be measured using
(2.2): ∫ d
0






This basic measure is made along all the rays between detector pixels and
the x-ray source for each projection angle around the imaged object. This yields
a set of projections taken at many different angles around the object. It is pos-
sible to reconstruct the attenuation values µ(·) of each point in the object using
those projections with a reconstruction algorithm based on the inverse Radon
transform. For cone-shaped x-ray beams, such as those used for micro-CT,
the Feldkamp reconstruction algorithm is the most well known and commonly
used [27].
2.3.2 Micro-CT image degrading factors
There are several sources of image degradation in CT due to physical limita-
tions of the system and algorithmic approximations. Some knowledge of how
the source generates x-rays and how they are detected is necessary to under-
stand those degradations.
The x-ray source in CT scanners, the x-ray tube, consists of a cathode that
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emits a stream of electrons and an anode that the electrons bombard, pro-
ducing x-rays mostly through bremsstrahlung interactions [44]. The cathode
assembly is negatively charged and contains a filament composed of tungsten
that, when a current is induced, produces free electrons through thermionic
emission [27]. The anode is positively charged and thus attracts electrons from
the cathode. This flow of electrons between the cathode and anode is referred
to as the tube current [44]. The anode is composed of materials with large,
high-Z nuclei to increase the chances that the electrons will interact and pro-
duce bremsstrahlung radiation, and to withstand the heat deposited in it by
the electron interactions. The quantity of x-rays produced depends not only
on the tube current, but on the electric potential (voltage) between the anode
and cathode. This difference is called the tube voltage and the higher it is, the
higher the energy and quantity of the generated photons. A simplified depic-
tion is shown in figure 2.4.
This process by which x-ray beams are created produces a random number
of photons traveling in the direction of any point on the detector. The absorp-
tion of any photon within the sample or detector is likewise probabilistic. This
means that even uniform materials scanned via CT will have a non-uniform ap-
pearance. In fact, the number of photons interacting with the detector at each
projection can be modeled as a Poisson random variable, which has a variance




Figure 2.4: A demonstration of electrons moving from the tungsten filament of
the cathode and flowing to the positively charged anode. The anode is composed
of high-Z, heat-tolerant materials such as tungsten and molybdenum that are
likely to produce x-rays when electrons are incident. The part of the anode at
which the electron flow is focused is the focal spot. The anode is sloped at the
focal spot to avoid anode-absorption of x-rays emitted in the correct direction.
However, the x-ray beam directed at the detector is still not uniform so addi-
tional hardware (not shown) is necessary to filter and shape the resultant x-ray
beam.
Reconstruction algorithms require that a windowed filter be applied to the
data to avoid amplifying noise in the reconstructed image [45]. This process
transforms the uncorrelated Poisson-like noise in each projection into corre-
lated noise, which changes the noise texture in the reconstructed image, as
shown in figure 2.5.
Figure 2.5: Example of CT noise patterns visible in a uniform water phantom.
In addition to the noise texture visible in image reconstructions, there is a
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limit to the distance between distinguishable objects in CT images. This dis-
tance is known as the spatial resolution of the system [27]. While two objects
less than a detector pixel distance apart can obviously not be distinguished,
there are many important factors affecting the spatial resolution of a CT imag-
ing system, such as the thickness of the detector, the size of the focal spot of
the x-ray tube, the physics of photon propagation, and the properties of the
reconstruction algorithm [27,45].
CT detectors contain a grid of light-sensitive elements that allow the two
dimensional detection of incident photons. These elements are much more sen-
sitive to lower-frequency light, and so a thin scintillator is typically placed be-
tween the detector and the x-ray source. The scintillator converts incident x-
rays into lower-energy photons through fluorescence and decreases the amount
of x-ray exposure necessary to create a projection by increasing the detector
sensitivity. The sensitivity of the detector is directly related to the thickness of
the scintillator, as higher energy photons are more likely to be stopped. How-
ever, the thickness of the scintillator also directly affects the resolution of the
system. The depth of the x-ray interaction in the scintillator affects how many
detector bins measure incident photons, and consequently, how blurred an in-
cident photon will be.
Another cause of resolution degradation is that the x-rays are emitted from
an area source, not a single point. While the design of the x-ray tube attempts
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to focus the tube current on a single focal spot of the anode, there are invariably
deviations in impact location that cause x-rays to be emitted from different
locations around the focal spot. Geometrically, this source location uncertainty
increases the blurring observed at the detector.
This effect is exacerbated by magnification that occurs the closer the imaged
object is placed to the x-ray source. This effect is particularly noteworthy in
micro-CT scanners, which deliberately move the imaged object closer to the x-
ray source so that smaller volumes can be imaged with larger detector pixel
sizes.
Finally, when photons pass through the sample, some will be absorbed due
to the photoelectric effect, some will be scattered, and some will pass through
the sample and be detected. Some scattered photons may still arrive at the
detector and result in incorrect incident intensity measures in the projections.
For CT systems imaging large volumes, detections of scattered photons can be
mitigated by including anti-scatter grids that attempt to attenuate photons not
traveling along rays from the source at the cost of decreasing detector sensitiv-
ity, but for micro-CT systems imaging smaller volumes, this is usually omitted
due to the very small detector pixel size.
While noise and system blurring are very common image degrading factors,
others are also relevant to this work and thus require some explanation. Equa-
tion (2.2) used an approximation that x-ray beams are mono-energetic in order
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to make estimating attenuation values at each voxel of the reconstructed im-
age tractable, the x-ray beams produced by bremsstrahlung interactions are
actually poly-energetic. As a poly-energetic beam passes through a thick sam-
ple, the lower-energy photons are relatively much more likely to be attenuated
than higher-energy photons. This results in more photons arriving at the detec-
tor than would be expected for mono-energetic x-ray beams, which means that
the attenuation of the penetrated media will be underestimated. This phe-
nomenon is referred to as beam hardening. A common mitigation technique
uses copper and aluminum filters positioned between the x-ray source and the
sample to “pre-harden” the x-ray beam by removing low-energy photons before
they reach the sample.
Additional artifacts include streaks caused by attempting to estimate µ(·)
with insufficient projections and rings caused by broken or incorrectly cali-
brated detector elements.
2.3.3 Micro-CT microsphere detection
Glass microspheres (like TheraSphere) that are composed of borosilicate glass
doped with yttrium have a much higher attenuation coefficient than resin-
based spheres (such as SIR-Spheres) or tissue. While the average diameter
of the microspheres is very small compared to the resolution of clinical CT
scanners, some micro-CT scanners have the ability to resolve even smaller ob-
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jects [46]. This suggests that micro-CT imaging of tissue with embedded mi-
crospheres should have high contrast between voxels containing microspheres
and those without.
Marxen et al. demonstrated the feasibility of imaging silver- or gold-coated
polystyrene beads with approximately the same diameter as the glass micro-
spheres considered in this work [47]. However, the described method imaged
only a small volume and did so using twelve-hour (and thus very low-noise)
scans. Attempting to image similar objects using the same acquisition param-
eters on a larger tissue sample would require prohibitively long scans. Issues
with image resolution were also generally ignored. However, the ability to
characterize microsphere clusters using micro-CT could lead to improved un-
derstanding of microsphere and dose inhomogeneity, and eventually improved




Development of a Customizable
Hepatic Arterial Tree and
Particle Transport Model for Use
in Treatment Planning
3.1 Introduction
The use of RE for treating metastatic and primary liver cancers is increasing
due to its ability to deliver high treatment doses to tumor tissue and low doses
to normal liver parenchyma, thus reducing liver toxicity compared to EBRT [7].
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Treatment is performed by inserting a catheter into the HA and administering
radioactive microspheres that embolize the microvasculature and deliver ra-
diation near the location of embolization. Due to the tumors’ primary use of
arterial blood [7], particles are likely to be trapped near and deliver a high
absorbed dose to tumors while sparing normal liver structures.
Other approaches, such as fractionated EBRT, induce toxicity at much lower
doses than RE, and this may not allow a fatal dose of radiation to be delivered
to tumors [19]. Optimal treatment plans for RE must deliver sufficient dose
for tumor control while avoiding complications such as radiation-induced liver
disease due to excessive dose to normal tissues. Treatment planning for RE
using glass microspheres principally uses the total mass of the treated liver
volume to calculate the mean dose [48]. This planning method aims to deliver
a desired average dose to the treated volume and does not account for tumor
burden, the ratio of microspheres trapped in tumors versus normal tissues,
and their effects on dose heterogeneity. Thus, dose delivered to tumors varies
across patients, and this can result in a lower probability of tumor control due
to under-dosing of the tumor [34]. The calculation of dose to normal liver tis-
sue is complicated by the non-uniform distribution of microspheres within that
tissue and the unique microstructure of the liver itself [11].
Because of the relatively short range of the 90Y beta particles and their
nonuniform distribution in the anatomy, it has recently been suggested that
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the dose at a microscopic level is highly non-uniform, and that this affects
the radiation toxicity of normal tissues [11]. Accurately predicting the dose
to normal liver tissue at a microscopic level through modeling of patients’ liver
microanatomies could allow dose adjustment and improve the outcomes of pa-
tient treatment. In order to effectively model particle distribution within a
given patient’s vasculature, a realistic model of that vasculature is required.
However, at present there is no method to map the microvasculature in vivo.
Also, there are differences in the distribution of particle diameters that may
affect the final trapping locations of spheres within the microvasculature. The
details of this trapping depend, in principle, on details of the vessel diameters,
blood pressure, and mechanism of trapping.
Bézy-Wendling et al. proposed a method to create a realistic representation
of hepatic vasculature based on measured physical properties and an optimal-
ity criterion that minimized local vessel volume [49]. The method uses macro-
cells to incrementally extend an initial vascular tree to perfuse an existing liver
shape. The vessels in the generated tree split and taper realistically after each
bifurcation from the proper hepatic artery (PHA) to the macrocell connection
points.
In their work, however, vessels were generated down to regions two hundred
times larger than the size of a macrocell representing a terminal arteriole [30].
At this scale, the terminal vessel diameters are larger than the average diam-
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eter of the infused microspheres in RE [50]. Also, without generating vessels
down to dimensions of the THA diameters, it is difficult to check the validity
of the tree generation method as most data have been collected for initial and
terminal vessels. Also, if the vessel diameters in the resulting vascular tree
model are larger than the sizes of the infused particles, the tree will not be
useful for modeling the trapping of microspheres at a microanatomical scale.
Walrand et al. have developed a model of the liver microanatomy, the hep-
atic arterial tree, and the microsphere infusion process for high-activity, glass
microspheres [10, 11]. The tree was generated using an initial hepatic arte-
rial tree supplying the eight liver segments. Those segments were filled with
hexagonal prisms that represent the lobule, a functional unit of the liver with
blood flowing in at each corner through portal tracts containing one or more
THAs and portal venules [18]. To generate a tree from the THAs, each arteriole
was chosen at random and connected to the nearest existing vessel that would
not result in retrograde flow. Blood flow in each vessel was determined based
on the number of terminal arterioles supplied by the vessel or its descendants.
This model did not estimate the diameters of any intervening vessels nor take
into account blood flow or pressure differentials when generating the tree.
Walrand et al.’s particle trapping model assumed that all particles are trapped
in THAs and that particle flow at bifurcations is probabilistic and based on both
flow and the relative geometry of the child vessels. Simulated images of the
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activity distribution after a simulated RE procedure had a texture that was
qualitatively similar to that observed in PET/CT images. However, the tree
produced by this method does not follow observed physical properties. This
may impact the heterogeneity of particle and dose distribution. Additionally,
the assumption that each particle arrives at a terminal arteriole is unlikely
given the range of diameters of microspheres [48] and the measured diame-
ters of the arterioles [21]. Högberg has demonstrated that resin microspheres,
which have diameters similar to glass microspheres, are frequently trapped in
non-terminal vessels [51].
In this work, we propose a method to generate a vascular tree using a liver
volume and the larger branches of the hepatic arterial tree that can be es-
timated from patient scans. The simulated tree conforms to relevant physical
laws and can be adapted to match measured pressure differentials, blood flows,
viscosities, and vessel diameters. The blood flow patterns and pressures can be
customized for individual patients; e.g., using data from patient scans or mea-
sured via a catheter. We also propose a new method to model the infusion
and trapping of embolizing particles in those trees that considers the diame-
ters of both the particles and trapping vessels. These can be used to produce
estimates of the particle distribution that could be useful for exploring the mi-
croscopic dose distribution in normal liver tissues and predict normal tissue
dose on an individualized basis.
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3.2 Methods
In this work, we have developed a method to generate a hepatic arterial tree
from the PHA to individual THAs. This method uses the macrocell-growth
algorithm described by Bézy-Wendling et al. [49]; various model parameters
are adjusted dynamically during tree growth to produce desired quantities of
interest such as THA diameters. As will be described below, the binary trees
generated using this method conserve matter, conform to Murray’s law at all
bifurcations, and follow Poiseuille’s law within each vessel.
3.2.1 Conservation of matter
To conserve matter, the volume of blood flowing into each vessel equals the
volume flowing out of its children, or
Qp = Qc1 +Qc2 , (3.1)
where Qp and Qcx are the volume flow of blood, modeled as an incompressible
fluid, passing through the parent and child vessels. At the highest level, the
flow from the PHA equals the total volume of blood flowing out of all terminal
arterioles. In this work, we chose to have equal flow to each terminal arteri-
ole, though non-uniform flow distributions could be incorporated if there was
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knowledge of local relative flow, e.g., from perfusion imaging.
3.2.2 Murray’s law
Murray’s law describes the relationship between the diameters of a parent





c2, where rp is the radius of the parent vessel, rcx. is the radius of each
child vessel, and γ is the bifurcation constant. Murray originally suggested
γ = 3 to minimize the power necessary to provide adequate blood flow [52], but
it is generally accepted that γ varies, depending on the type and caliber of the
vessels, from 2 in larger arteries near the heart to 3 in smaller vessels [53]. We
have chosen γ based on the vessel diameter ratio (VDR), i.e., the ratio of the di-
ameter of the PHA (4.5 mm [54]) and the average THA diameter (11.8 µm [21]).
For a balanced binary tree with equal child vessel diameters, the relation be-
tween the parent and child vessels may be expressed as a scalar
rp = 2
1
γ · rc. (3.2)







The value of n may be estimated for a balanced binary tree with the expres-
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sion log2 (number of THAs). The number of THAs can either be determined by
filling the liver segmentation with THAs or be estimated by dividing the vol-
ume of the liver by the volume of a lobule (1.87 · 10−3 mL) and multiplying by
two, as the six portal tracts of a lobule are shared by three other lobules. Thus,
an expression to calculate the bifurcation constant for a balanced binary tree,
given vessel diameters and the number of THAs, is
γ =
log2 (number of THAs)
log2 rPHA− log2 rT HA
(3.4)
Trees generated in this work were unbalanced, which affects both n and γ.
The error caused by using (3.4) for unbalanced trees was assessed by observing
the percent differences in VDR for trees generated with values of γ between 2
and 3.
3.2.3 Poiseuille’s law
Poiseuille’s law [49] gives the pressure differential (∆P) between the extremes
of a cylinder as a function of the length (l) and radius (r) of that cylinder, and





While blood is not a Newtonian fluid [55], and arterial flow is not laminar
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[52,53], Poiseuille’s law is still commonly used to model physical parameters of
individual vessels [49,53]. The choice of Murray’s bifurcation constant controls
the VDR, but the generated vessel diameters depend on l, µ, ∆P, and Q. The
values of these parameters used in this work are justified below.
The length, l, of a particular vessel is not directly controllable using the
macrocell-based generation method. Instead, it is dependent on the locations
of the PHA and macrocells and on the optimization criteria used to determine
vessel bifurcation points, as discussed below.
The viscosity, µ, of blood depends on factors such as the hematocrit, plasma
content, and vessel diameter [55]. Bézy-Wendling et al. argued that treating
blood viscosity as a constant is a reasonable first approximation [49]. Thus, the
effects of modeling blood as a non-Newtonian fluid were not considered in this
work; we approximated blood as a fluid with constant viscosity of 3.5 mPas [56].
A wide range of pressures in the PHA and THAs has been measured across
populations and within individuals [18,57,58]. In this work, we typically used
98 mmHg as the pressure at the input of the PHA [59] and 25 mmHg as the
output pressure at each THA [18].
The flow of arterial blood, Q, is also highly variable [59] and depends on
both the input blood pressure and the flow within the portal vein [57]. Unless
otherwise noted, we adjusted the arterial blood flow to produce an average THA
diameter consistent with that reported in the literature.
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3.2.4 Tree generation
Vessel trees were generated using the macrocell-based approach described by
Bézy-Wendling [49] and Kretowski [59] that simulates the growth of the liver
and its vascular tree over a series of 15 cycles. The macrocells represent THAs
whose locations are the corners of hexagonal prisms arranged in a lattice as
described in the virtual arterial tree by Walrand et al. [10]. The growth process
starts with an initial segmentation of the hepatic artery and the liver shape.
In the work presented here, the liver shape was taken from the XCAT phan-
tom [60] and has volume 1.75 L. The initial hepatic arterial tree was also taken
from the XCAT and has 3 branching levels. Both could instead be segmented
from patient images. The liver shape is filled with lobules as done for the vir-
tual arterial tree in Walrand et al. [10], and the THA locations in the lobules
are stored as the potential macrocell locations. The initial tree, liver shape, and
macrocell locations are then scaled to one-twentieth of the final model volume.
Active macrocell locations are chosen such that the number of macrocells per
unit volume is the same for all cycles without being too close together. For the
first cycle, then, one-twentieth of the macrocell locations are designated as ac-
tive and unoccupied. During that cycle, those macrocell locations are occupied
through the proliferation of macrocells over a series of subcycles.
During a subcycle, each macrocell has some probability of mitosis (dividing)
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and apoptosis (dying), as shown in figure 3.1.
At the start of each cycle, every macrocell is tested to determine if it will di-
vide, die, or remain unchanged. A new macrocell is generated for each dividing
macrocell, and the new macrocell occupies a nearby, active location, if avail-
able, and is connected via a new vessel to the nearest branch of the existing
hepatic arterial tree. The connection point is controlled by physical principles
that optimize the flow of blood through those vessels and is discussed below.
If there are no nearby unoccupied, active locations, then the new macrocell is
removed. The order in which new macrocells are processed is random. When
a macrocell is marked for deletion, the vessels connecting it to the tree are
removed and flow values in parent vessels are recalculated.
The process of mitosis and apoptosis in subcycles continues until the cycle
termination criterion is reached. The termination criterion is that more macro-
cells die than are created in a subcycle, which indicates that nearly all active
macrocell locations are occupied. At that point, the current cycle is ended, and
the liver volume, hepatic arterial tree, and potential macrocell locations are
scaled up linearly to fill a larger liver volume. A superset of potential macro-
cell locations are identified as before, and a new set of subcycles begins until
the cycle termination criterion is reached. These cycles continue until the liver
matches its original volume.
During later cycles, when the number of vessels is in the tens of millions,
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Figure 3.1: Probabilities of macrocell mitosis and apoptosis as a function of
growth cycle number. Note that the probability of mitosis is always higher
than that of apoptosis, leading to the shape eventually filling as the subcycles
progress.
searching for the nearest vessel to a proposed THA location can take a sig-
nificant amount of time. This was mitigated by storing vessel locations in an
octree data structure [61], reducing the complexity of searching from linear to
logarithmic.
When macrocells are added to the model, the nearest vessel is bifurcated to
supply blood to both the new macrocell and the vessel’s previous perfusion area.
When this occurs, an optimality criterion determines the location of the bifur-
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cation point [49]. Zamir et al. investigated several optimality criteria, including
minimizing the power to pump blood through a junction, and minimizing vessel
surface area, volume, or shear stress at a junction [62]. However, there is not
consensus on which optimality criterion is most physiologically realistic [63].
Bézy-Wendling et al. chose to minimize local vessel volume to determine the op-
timal bifurcation point [49], which minimizes the amount of blood required to
perfuse the organ and the time it takes for blood-borne items to circulate [63].
Fung et al. chose to minimize the shear stress on vessel walls [64], which has
the benefit of determining the bifurcation point based solely on information
available to each locally growing vessel [63]. The derivation in [64] supplies
a formula for choosing the optimal point for a bifurcation that depends only
on the vessel endpoints and the relative flow in each vessel. This reduces the
computational effort necessary to choose bifurcation points. Due to the large
number of vessels being generated in this work, we minimized the shear stress
on vessel walls as described by Fung. During tree growth, the vessel diameters,
pressures, and flow rates are periodically computed as described by Kretowski
et al. [59]. In this method, vessel diameter is the dependent variable and the
change in pressure, blood flow, and vessel length are independent variables.
Using this method to generate a tree with correct THA diameters requires that
the flow (or other variable) be adjusted after construction is finished. The flows
are adjusted as follows: After the tree is generated and K macrocells perfused,
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there is one path from the PHA to each macrocell. For each path, we can write







where nx. is the number of vessels in path x, and Qxi,lxi, and rxi are the flow,
length, and radius of the ith segment of path x. Here we wish to change the
total hepatic flow, Q, to achieve a particular average THA diameter without
changing any other parameters. Due to (3.1), scaling Q by a factor results in
each Qxi being scaled by the same factor. The result for each rxi is complicated
by the non-linear constraint imposed by Murray’s law. If we use the same
assumption used in (3.2) and (3.3), we can rewrite (3.6) in terms of rT HA, the






π24(i−1)/γ · r4T HA
(3.7)
Equation (3.7) remains balanced if, for any scalar α applied to rT HA, each
Qxi (and by extension, Q) is scaled by α4. The validity of the simplification was
tested by comparing the average THA diameter for different Q and ∆PALL with
the predicted diameters, as described below.
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3.2.5 Trapping model
In addition to a model of the hepatic arterial tree, we have adapted the particle
trapping model developed by Walrand et al. to take into account the diameter-
distribution of the particles and the diameters of the vessels. The modified al-
gorithm operates by randomly sampling a diameter from the particle diameter-
distribution and placing a particle of that size into the initial vessel of the tree.
The particle then flows through the tree until it arrives at a vessel that is either
too narrow for the particle or is a terminal arteriole. At each bifurcation, the
particle randomly enters the left or right child vessel, depending on the ves-
sels’ geometries at the bifurcation and the division of blood flow, as described
by Walrand [10]. The particle is trapped if both vessels are smaller than the
particle diameter, but, if only one vessel is too small, the particle enters the
larger vessel. We simulated the effect of embolization by linearly reducing flow
through a vessel, in proportion to the number of particles trapped in it, until 50
particles are trapped and flow to that vessel stops. After a particle is trapped
and the flow in the vessel adjusted, the flow and bifurcation probabilities are
recalculated for the whole tree.
Several 120 Gy whole-liver infusions were modeled for trees generated as
described above with average THAs of 11.8 µm. Further 120 Gy infusions were
simulated for trees with average THA diameters of 15.8 µm and 18.3 µm to com-
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pare the fraction of infused spheres arriving at THAs. All infusions were mod-
eled with particles simulating glass microspheres whose diameter distribution
was a truncated Gaussian with mean 25 µm and standard deviation 5 µm [19].
3.3 Results
Estimating the bifurcation constant that produces the correct VDR using (3.4)
with 1,868,346 THAs (estimated using liver volume), yielded γ = 2.43. Trees
generated using this method had an average of 1,849,429 macrocells, and each
terminal arteriole perfusing a macrocell had, on average, 435 bifurcations be-
tween itself and the PHA, which is much larger than the 21 bifurcations neces-
sary for a balanced tree. Figure 3.2 shows that the relative differences between
the expected VDRs for balanced trees and the VDRs for generated trees was
between 2% and 8% for a range of bifurcation constants. This indicates that
(3.4) is a reasonable means to estimate the bifurcation constant, despite the
asymmetry of the vessel tree.
Figures 3.3 and 3.4 show the relationship between the average THA diam-
eter and blood flow and pressure differential. Each figure shows the relative
error between the actual average THA diameter and the diameter predicted for
a balanced tree. In both cases, the error was much less than 1% of the predicted
value. This indicates that approximating the relationship between parent and
children vessels as a simple scalar, as in (3.2) and (3.7), does not have a signifi-
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Figure 3.2: (top) Ratio of PHA diameter over average THA diameter as a func-
tion of the bifurcation constant for a balanced binary tree and for several tree
realizations built in this work. (bottom) Error percentages between predicted
and observed ratios of diameters. The percent difference between the ratio
predicted using a balanced binary tree is less than 8%.
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cant effect on the relationship between flow, pressure, and the THA diameters.
It was thus possible to directly calculate the flow required to produce a tree
matching the desired average THA diameter.
Figure 3.5 illustrates the growth of the vessel tree from the initial hepatic
artery segmentation to the full-grown tree with γ = 2.428, Q = 75mL/min, and
∆P = 73 mmHg. At each cycle, the pressure, flow, and diameters were optimized
as described above to create a realistic tree whose vessels taper with successive
generations and for which blood flows with minimal drag. The generated tree
had a PHA diameter of 4.63 mm and a mean THA diameter of 11.79 µm with a
standard deviation of 2.45 µm.
After sphere distribution, a volume image with 2 mm pixel widths was gen-
erated. That image was then convolved with a 3-dimensional Gaussian filter
with FWHM 8 mm to create an image with resolution similar to that of 90Y PET.
A single coronal slice from near the center of the volume was extracted and is
displayed as figure 3.6.
A very small percentage of particles arrived in the THAs for any average
THA diameter tested in this work. Trees with 75mL/min total flow and 11.8 µm
average THA diameter trapped 0.087% of infused microspheres. For trees with
241mL/min flow and 15.8 µm diameters, the percentage increased to 0.103%.
Trees with 433mL/min flow and 18.3 µm average THA diameters had 0.116% of
microspheres trapped in THAs.
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Figure 3.3: (top) Average THA diameter as a function of the total hepatic ar-
terial flow for trees generated with pressure difference 73 mmHg and γ = 2.428.
(bottom) Error percentages between predicted and observed THA diameters.
3.4 Discussion
The relatively small errors between the predicted and observed VDRs indicates
that, at least for minimum drag bifurcation point optimization, the bifurcation
constant can be estimated without knowing a priori how the tree will grow, or
even how asymmetrical it will be. Furthermore, we investigated the effect of
modeling a different number of portal tracts on the value of γ needed to produce
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Figure 3.4: (top) Average terminal vessel diameter as a function of the pres-
sure difference between the PHA and THAs for 75 mL/min and γ = 2.428. (bot-
tom) Error percentages between predicted and observed THA diameters.
the desired THA diameter. We found that if each portal tract contains 2.4 THAs
on average (as noted by Crawford [21]), a value γ = 2.57 was calculated, which
is very close to the value measured in the coronary arteries of canines and that
minimizes reflection at bifurcations with equal child flow [65].
Figures 3.3 and 3.4 show that (3.7) is a reasonable method to choose a value
for flow or pressure difference that will produce a tree with the desired THA
or PHA diameters. Together with Kretowski’s original algorithm, this allows
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Figure 3.5: Tree growth from initial segmentation (top left), to cycle 4 (top
center left), cycle 8 (top center right), cycle 12 (top right), and cycle 15 (bottom),
which is the finished tree. Note that to aid visualization, the tree in earlier
cycles has been scaled such that the liver shape occupies the same area of each
image. Of interest is how the vessels taper in a manner comparable to true
vessels. This allows embolic effects to be modeled in simulations of particle
infusions.
each generated tree to be customized with respect to the different parameters
of interest such as pressure difference, blood flow volume, and average THA
diameter.
In this work, we adjusted flow to produce terminal vessels with an average
diameter matching literature values. However, the flow required for correct
diameters, 75mL/min, is lower than values reported in literature [57, 66]. If
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Figure 3.6: A coronal slice from a simulated 120 Gy, whole-liver infusion con-
volved with a Gaussian filter at PET resolution. The texture is similar to that
shown in Walrand et al. and indicates a heterogeneous distribution of spheres
that may be sparing of normal tissue [10].
a Gaussian curve is representative of the data collected by Carlisle et al. [66],
hepatic arterial flow of 75 mL/min or less would be representative of less than
3% of subjects measured. As our interest was in producing trees with reason-
able THA diameters, we decided to use this value of flow. Further refinements
to the flow model may help correct this apparent discrepancy, e.g., by modeling
blood as a non-Newtonian fluid [52] or determining the value of the bifurcation
constant at each junction in a more sophisticated manner.
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The standard deviation of the generated THA diameters was only half as
large as that reported by Crawford [21]. This resulted in many fewer termi-
nal arterioles larger than 25 µm than was reported in that work. The simu-
lations with larger THA diameters, despite having physically realistic values
for flow and percentage of THAs with diameter greater than 25 µm, resulted
in only slightly more particles being trapped in THAs. This is potentially im-
portant for predicting toxicity as the lobules contain physiologically important
and radiosensitive structures critical for liver function [30], and microspheres
trapped closer to them would deposit more dose in them. Nevertheless, the
data show that the differences in the fraction of spheres trapped in THAs was
less than 0.03% for the range of THA diameters investigated. The fact that
so few spheres were trapped in THAs may be important as sphere trapping
heterogeneity directly affects dose heterogeneity [11, 30] and may affect both
tumor dose and toxicity to normal tissue.
Figure 3.6 shows a simulated PET image slice that would be obtained using
an activity distribution generated using the models developed in this work. The
non-uniform texture of the slice is qualitatively similar to the texture observed
in patient images and those simulated by Walrand et al.
One potential application of the proposed method is the use of the diameter-
aware particle trapping model described in this work to compare infusions of
particles of different sizes. For example, the average diameter and standard
53
CHAPTER 3. TREE AND TRANSPORT MODELS
deviation of MAA particles are both larger than the same parameters for glass
microspheres; differences in microsphere versus MAA distribution could be
used to improve the accuracy of RE treatment plans based on measured MAA
activity distributions.
The particle trapping model described here allows vessels to fill with parti-
cles and may cause them to divert to other branches or trap in a parent vessel.
This yields more complex clusters than an algorithm that traps all particles in
terminal arterioles, as was assumed in Walrand’s original work [10]. A possible
method to validate the proposed particle trapping model is to perform cluster
analysis on the particle distribution and compare that with clusters observed
in actual treated liver tissue. As clustering behavior may be very important to
normal liver dose tolerance [30], producing realistic deposition patterns could
allow trees generated using this method to be used in treatment planning. Ac-
tivity distributions resulting from realistic clusters of spheres can also be used
to test and validate image reconstruction methods targeting improved estima-
tion of RE activity images.
Another potential improvement to this model is modifying the macrocells to
represent hypervascularized and necrotic tissue in addition to normal parenchyma.
Simulations with such tissue heterogeneity may capture important informa-
tion about the tumor dose and normal tissue toxicity.
This model has potential applications in patient-specific treatment plan-
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ning. In particular, the model of hepatic arterial vasculature can be made pa-
tient specific using imaging data in at least three ways. First, it can easily
be adapted to the shape of the liver of a specific patient, obtained, e.g., from
a CT image. Second, the initial vascular tree used to seed the vessel growth
algorithm could be obtained from high resolution CT or MR angiography im-
ages. Finally, perfusion patterns measured via MR or CT imaging or flow or
pressure measurements made using the catheter could potentially be used to
constrain these parameters in the images. All of these together could provide a
patient-specific model of the vasculature and, when combined with a model of
particle trapping, be used to estimate dose distributions at a microscopic level.
Combined with radiobiological models [11], this could provide patient-specific
estimates of liver toxicity.
3.5 Summary
In this work, we have presented a new method for generating realistic models
of the hepatic arterial tree using a macrocell growth technique. The generated
tree conserves mass, satisfies Murray’s law of vessel diameters at bifurcation
points, and uses Poiseuille’s law to calculate the pressure change through the
vascular network. Physical parameters describing blood flow through the tree
were based on literature values and modified to provide realistic average diam-
eters for the terminal hepatic arterioles. A model for trapping particles with
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a known distribution of diameters was developed. The combination of these
methods is useful for generating realistic activity distributions to validate im-
age reconstruction methods and to explore the effect of various parameters,
including differences in particle diameter distribution, on the microscopic dose
distribution. The method allows for specification of the initial hepatic arte-
rial tree, patient volume, and local variations in blood flow, providing future
potential for improved patient-specific treatment planning.
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Verification of a Method to Detect
Glass Microspheres via Micro-CT
4.1 Introduction
Yttrium-90 (90Y) RE is a widely-used treatment for unresectable liver cancer
involving the administration of radioactive, embolic microspheres into the hep-
atic artery. RE has an advantage over conventional external beam radiation
therapy because the average dose delivered to liver tissues can be significantly
higher [11,19] with minimal toxicity to uninvolved hepatic parenchyma. How-
ever, advancing treatment planning methods in RE requires a greater under-
standing of how microspheres deposit in normal and tumor tissues, as mi-
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croscopic analysis has shown that microspheres trap in clusters during the
infusion process [67]. This heterogeneous distribution of microspheres is be-
lieved to be crucial in explaining the observed normal-tissue-sparing effect [8]
and the high tumor doses [67]. Complete three-dimensional (3D) characteri-
zation of microsphere distributions within tissue samples could enable micro-
scale dose analysis of the tissues and comparison of the calculated doses with
histological analyses of tissue samples to find correlated tissue effects. Ad-
ditionally, several authors have proposed methods for generating models of
liver vascular anatomy and simulating the transport and trapping of micro-
spheres [10, 11, 15, 68]. Walrand et al. have specifically described a radiobio-
logic model that considers both microsphere clustering and tissue structure to
predict the risk of toxicity in liver tissue [11]. The accuracy of those models
depends on how realistically glass microsphere clustering is simulated, and a
small-scale analysis of microsphere distributions in tissue would provide data
to validate those models.
Traditional methods to determine microsphere locations are manual and
labor- and time-intensive processes that involve dividing small sections of liver
into many thin slices (∼5-200 µm), staining them, taking optical micrographs,
and noting the two-dimensional locations of microspheres [43, 67, 69–72]. In
the literature, analyses of only small regions using this method have typically
been reported [43, 67, 71, 72], likely due to the effort involved in preparation
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and scanning. Further, sphere locations and cluster sizes can typically be char-
acterized in only two dimensions, due to the complexity and extreme care nec-
essary to collect spatially comparable data from consecutive slices thin enough
to be visualized under light microscopy [43]. The FDA has approved two va-
rieties of microspheres to treat liver cancers, SIR-Spheres (SIRTEX Medical
Limited), a polymer-resin microsphere that has been labeled with 90Y with
mean diameter of about 32 µm, and TheraSphere (Biocompatibles UK Limited)
an yttrium-doped borosilicate glass microsphere with mean diameter of about
25 µm [69]. While the typical process of sectioning tissue via microtome is able
to slice polymer-based microspheres without sphere motion [43], its effect on
glass microsphere locations, whether due to the blade dragging spheres down-
ward during slicing or by moving microspheres in a direction normal to the
plane of the slice, has not been reported.
This work describes and verifies a method to estimate the quantities and
three-dimensional locations of glass microspheres in whole tissue samples us-
ing a high-resolution micro-CT scanner and an automated image analysis al-
gorithm. This method allows microdosimetry and clustering behavior evalu-
ation in large sections of ex-vivo tissue without requiring the involved, time-
consuming tissue sectioning and scanning process.
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4.2 Materials and methods
Use of patient data included in this manuscript was approved by the Johns
Hopkins Hospital Institutional Review Board.
The process of analyzing micro-CT images to detect and localize 90Y glass
microspheres occurs over three stages. Stage I takes advantage of the large dif-
ference between the attenuation coefficients of the microspheres and the back-
ground medium (e.g., liver tissue) by using intensity thresholding to detect re-
gions that contain microspheres. Stage II, sphere quantification, estimates the
number of microspheres in each detected region using the voxel values in that
region. Stage III, sphere localization, uses both the detected regions and the
estimated sphere quantities in each region to estimate a three-dimensional lo-
cation for each microsphere. Degrading factors inherent in CT images, such as
noise due to the probabilistic nature of x-ray beam transmission and detection,
system blurring due to geometric properties of the CT system, photon scatter
and penetration during imaging, and other artifacts such as beam hardening or
rings, require parameter choices to be coordinated between stages to mitigate
their effects and produce the best overall detection and localization results.
Detection and localization algorithm performance was measured using a phan-
tom with embedded microspheres that could be scanned both optically and via
micro-CT. The utility of the algorithm was then demonstrated by processing a
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human tissue sample.
4.2.1 Phantom preparation and imaging
Phantoms that could be scanned via micro-CT and verified using an indepen-
dent modality were generated to characterize the performance of the algorithm
for this system. Following the basic approach described by Marxen et al. [47],
the phantoms were generated by sandwiching an agar/microsphere solution
between plastic coverslips. Those coverslips were sealed and fixed to thin, opti-
cally transparent plastic sheets using a toluene-based mounting medium. The
phantoms were placed on a microscope slide only for transmission light micro-
scope scanning, shown in figure 4.1a; during CT scanning the slide was not
present, as would be the case for scanning tissue samples, to avoid the influ-
ence of the highly attenuating microscope slide on boundary regions. Optical
micrographs of the phantoms were taken with a pixel size of 2.2 µm in 96 sepa-
rate images that were stitched into a larger composite image using phase cor-
relation and simple image translation. Two-dimensional microsphere center
locations were then recorded manually.
Sixteen hours after the phantoms were created and optically scanned, they
were gently stacked between Styrofoam slabs, wrapped in Parafilm, and scanned
using a SkyScan 1176 micro-CT scanner to detect the embedded microspheres,
as shown in figure 4.1b. A total of 656 high-resolution projections spaced 0.3
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(a) (b)
Figure 4.1: (a) Each phantom was scanned via transmission light microscopy
and two-dimensional microsphere locations found in the micrograph were
recorded. (b) To prepare the phantoms for micro-CT scanning, several phan-
toms were gently stacked between Styrofoam pieces and wrapped in Parafilm.
That package was placed above phantoms filled with water and formalin that
were scanned to allow the CT image voxels to be transformed into Hounsfield
units (HU).
degrees apart with a projection bin size of 8.74 µm were taken of the phantoms.
The tube voltage was set to 90 kVp for the scans and each projection was col-
lected twice, resulting in a total exposure of 0.695 mAs for each projection angle.
To mitigate the negative effects of beam hardening on detection performance,
both copper and aluminum filters were used. The resulting projections were
reconstructed using NRecon (SkyScan) 1.7.3, to produce images with 8.74 µm
voxels. Software-based beam-hardening correction was disabled due to erratic
effects on quantification, but ring artifact and interior reconstruction correc-
tions were enabled to improve scan uniformity.
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4.2.2 Detection and localization algorithm development
and verification
4.2.2.1 Stage I: Region detection
The first step in detecting regions containing microspheres was to choose an
intensity threshold between the attenuation coefficient of the background and
the microspheres. Noise in the reconstructed images could cause background
voxels to exceed the detection threshold and appear as spurious detected re-
gions. In high-resolution scans where one microsphere occupied many con-
tiguous voxels, such spurious regions could be ignored by detecting and re-
moving the smallest connected components of the image via area filtering with
26-connectivity [73], represented as Ψarea below. Groups of connected voxels
whose values exceeded the detection threshold are referred to as detected sub-
regions in this work. Noise could cause variations in the voxel values of the
sub-regions, and partial volume effects due to blurring could spread sub-region
voxel intensities into neighboring voxels. Thus, considering the lower-intensity
neighboring voxels in addition to the voxels in the detected sub-regions was
used to mitigate the impact of these effects on later stages. This was achieved
by dilating those sub-regions into full regions by a spherical structuring el-
ement, B, with radius dr [74]. The result of the region detection stage was
represented as the connected components of IRall , the binary image marking all
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detected regions described by
IRall = Ψarea (I > t,n)⊕B (4.1)
where I is the CT image, t is the detection threshold, and n is the minimum
sub-region volume. The choices of these parameters affected not only the accu-
racy of region detection, but also subsequent stages. For example, the thresh-
old and minimum volume were chosen with consideration for both the number
of spurious regions and erroneously omitted regions that resulted. However,
as parameter choices affected not only the accuracy of region detection but all
later stages, optimal choices of these parameters also depended on the capabil-
ities and deficiencies of those stages.
4.2.2.2 Stage II: Microsphere quantification
After finding the CT image regions containing microspheres, the next stage
was estimating the number of microspheres in each region. This was accom-








1R(i, j,k) ·µ(i, j,k) (4.2)
where IR is the integrated intensity of region R, 1R is the indicator function of
the region and µ(·) is the linear attenuation coefficient at each location in the
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image. Real tissue contains inhomogeneities, but as the attenuation coefficient
of the microspheres was both uniform and much higher than the background, it
was possible to ignore those inhomogeneities and treat the system as if it were
composed of two uniformly attenuating media: background and microsphere.









where vvox is the volume of a voxel, vsphs is the combined volume of all
spheres in the region, vR is the volume of the region, and µbg and µsph are the
attenuation coefficients of the background and microspheres, respectively. As-
suming the region contains the full volume of each microsphere, the volume of











where vsphi is the volume of microsphere i, and n is the number of microspheres
in the region. If spheres in region R are assumed to all have diameters of 25 µm
then the total estimated volume is vsphs ≈ n · vsph, where vsph is the volume of
the average microsphere. If the number of spheres in region R is high, then the
approximation for vsphs is likely to be more accurate, as variations in sphere vol-
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ume would tend to average out. For smaller regions, there is a greater chance
of misestimating the integrated intensity of that region.








A further assumption is that the region detection method produces regions
whose volumes scale linearly with the number of spheres contained in them
(i.e. m · vRn = n · vRm, where vRm and vRn are the volumes of regions containing m










= n ·ζ , (4.6)
where vR1 is the detected volume of a region with a single, average-size mi-
crosphere. The method, referred to as with-background (WBG), described in
equation (4.6), estimates that the number of spheres in region R by calculating
the integrated intensity of the region and dividing by a scalar factor, ζ .
However, the assumption that the volume of a region containing many spheres
is proportional the volume of a single-sphere region is only true for an ideal sys-
tem. With system blurring, the size of a detected region depends not only on
the threshold chosen, but on the relative microsphere positions within the de-
tected region volume. It is possible to reduce the influence of the region volume
66
CHAPTER 4. CT-BASED MICROSPHERE DETECTION










= n · ζ̂ (4.7)
where ÎR is the integrated intensity of the region above the background at-
tenuation coefficient, and ζ̂ is the corresponding scalar factor relating the num-
ber of spheres in a region to the intensity over background.
Equation (4.7), referred to in this work as the no-background (NBG) method,
eliminates assumptions about the relationship between the number of con-
tained microspheres and total region volume but retains much of the simplicity
of the WBG method.
Image degrading factors could also contribute to errors in sphere quantifi-
cation. Both the WBG and NBG methods could be affected by noise within the
regions, as it could increase or decrease the measured attenuation coefficients
of the contained voxels. This, in turn, could result in over- or underestimation
of the number of spheres in those regions. Sphere quantification accuracy could
also be impacted when system blurring caused intensity from microspheres in
a region to extend beyond the detected region boundaries, resulting in quantifi-
cation considering only some of the voxels affected by microsphere intensities.
If the regions considered for microsphere quantification were dilated by an ap-
propriate value of dr, then both degradation issues could be mitigated. Given an
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appropriate dilation radius, the integrated intensities of larger regions should
exhibit less deviation than undilated regions, and all voxels influenced by mi-
crosphere intensities will have been included in each region. The accuracy of
the NBG method should not be overly sensitive to the choice of dr, provided
it is large enough to mitigate the errors described above. However, the WBG
method is expected to be much more sensitive to the choice of dr, as it would
affect the accuracy of the assumption that region volumes scale linearly with
the number of microspheres contained in them. Therefore, the optimal dilation
radius during region detection should depend on the quantification method to
be used. This exemplifies the fact that optimal quantification could require
adjustments to region detection parameters.
As another example, if degrading factors caused spurious regions in the
first stage, it would seem reasonable to adjust the detection threshold to min-
imize the total number of spurious and incorrectly omitted regions. However,
because both methods used for the sphere quantification stage were capable
of determining when regions had no microspheres, and were thus spurious,
they could not detect spheres in regions omitted in stage I. Thus, minimizing
the number of incorrectly omitted regions is, for these quantification methods,
more important than minimizing the number of spurious regions.
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4.2.2.3 Stage III: Microsphere localization
The final stage uses the microsphere quantities estimated in stage II and the
detected sub-regions found in stage I to estimate locations for each detected
microsphere. As with the previous two stages, localization could be impacted
by image degrading factors, such as noise, which could cause bright points in
areas where there were no actual microspheres, and system blurring, which
could cause microsphere peaks to lose sharpness or even merge. There are
a variety of potential methods to estimate microsphere locations from the de-
tected regions and estimated sphere quantities. If localization were relatively
less important than quantification, then assuming the microspheres were dis-
tributed proportionally among the voxels of the detected sub-regions would
have been sufficient. However, as described above, the proposed method was
developed in order to accurately analyze the micro-dose deposition of 90Y emit-
ters. The sharp peaking of the 90Y dose kernel means that incorrectly local-
ized microspheres could have a significant impact on the dose distribution
error. Thus, accurate, discrete microsphere location estimation would likely
result in substantially increased dose distribution estimation accuracy. The
simplest method investigated for estimating a discrete location assumed that
all n microspheres detected in a region were co-located at the region’s centroid.
Similar to the proportional-distribution method above, this could produce in-
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accurate dose maps where an excessively high dose was estimated for the cen-
troid voxel, and insufficient dose was estimated for all surrounding voxels. A
more realistic method was to place the n microspheres at the n largest local
maxima of the sub-region voxels. This would partially address the issue with
co-locating microspheres, but localization inaccuracies would remain due to
noise in the sub-regions and blurring between microsphere peaks. If those er-
rors were mostly due to microsphere location estimates being unrealistically
close together, then a refinement would be to select the n largest local max-
ima subject to the constraint that sphere center locations were separated by
the average microsphere diameter. This method, referred to in this work as
well-spaced local maxima, potentially suffers from errors due to non-uniform
microsphere sizes and noise in the sub-regions. Another investigated approach
used voxel-weighted k-means cluster analysis to identify n distinct partitions
within the detected sub-regions and stored the centroids of each cluster as the
localized microsphere centers. Using clustering should avoid issues with co-
located microspheres and mitigate issues with noise, assuming the voxel val-
ues in a sub-region are more heavily affected by microsphere intensities than
noise. However, this clustering method could still suffer from typical k-means
issues, such as producing different results in different runs, or converging to a
local minimum.
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4.2.3 Algorithm verification
To compare the micro-CT scans to the optical micrographs, a maximum-intensity
projection (MIP) of the CT image was created along the vector normal to the
plane of microspheres. A projective mapping was then estimated between the
CT MIP and the optical micrograph using common features visually identified
in the two images. Region detection was performed on the full CT image, and
those three-dimensional regions were projected to a plane along the same vec-
tor. In the rare case that two regions overlapped along that axis, the larger
region was chosen to occupy the shared area of the resulting two-dimensional
image. The microsphere locations, marked in the phantom, were projected into
the MIP image space of the micro-CT and each was assigned to the region
overlapping it, if any. Peripheral regions of the phantom that showed obvious
shifting due to agar desiccation were excluded.
Optimal parameters for the detection and quantification methods, includ-
ing least-squares estimates of ζ and ζ̂ , were determined using the integrated
intensity, the integrated intensity above background, and the true number of
microspheres within each detected region of one phantom. A different phantom
was then processed, using the parameters estimated from the first phantom in
the analysis, to estimate microsphere locations using the methods described
above.
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4.2.4 Performance evaluation
For each stage of the algorithm, different metrics best characterized perfor-
mance. For region detection, the optimal thresholds, minimum sub-region vol-
umes, and dilation radii could be approximated by testing a range of values
and determining the percentage of microspheres contained within regions and
the percentage of regions that actually contained spheres. Best performance
for this stage minimized the number of spurious regions without incorrectly
decreasing the number of microspheres detected.
After detecting potential regions containing spheres, the number of spheres
in each region was estimated using the WBG and NBG quantification meth-
ods. The mode of the voxels outside of regions in the same plane as the mi-
crospheres was used as the background attenuation coefficient. Overall stage
performance was evaluated by first considering each region individually, then
aggregating the region performance data for the whole phantom. Specifically,
for each region the number of microspheres was estimated and compared to
the true number observed in the optical micrograph, and the number of true
positives (TPs), false negatives (FNs), and false positives (FPs) were recorded.
As an example, if a region contained M microspheres but the number estimated
was M+N, then M TPs and N FPs were recorded. Conversely, if the number es-
timated was M−N, then M−N TPs and N FNs were recorded. Performance for
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the whole phantom was reported by aggregating those results to calculate the
true positive fraction (TPF), the number of TPs divided by the total number of
spheres, and false positive fraction (FPF), the number of FPs divided by the to-
tal number of spheres [47]. Optimal choices for the algorithm parameters were
those that maximized the difference between the TPF and FPF. The impact of
changes in the region detection parameter on the performance of the sphere-
quantification stage was evaluated by testing the same parameter ranges as in
region detection and examining the resulting TPF and FPF.
Because ζ and ζ̂ were found using least-squares estimation, it is possible
that larger, more attenuating regions would have an outsized influence on the
final estimates of these parameters. To allay those concerns, 10,000 estimates
of ζ and ζ̂ were found using bootstrapping, and the 95% confidence intervals
of the TPF and FPF were examined. The 95% confidence interval for the total
number of estimated microspheres was also calculated to check the accuracy of
this method for estimating the total dose to a scanned region.
Radiation absorbed-dose maps were created by convolving a dose-voxel ker-
nel (DVK) with a 3D time-integrated activity map formed using the estimated
microsphere locations. The DVK was calculated for 72 µm voxels using MCNP-
6 (Monte-Carlo N-Particle, Los Alamos National Laboratory, Los Alamos, NM)
[75] with the 90Y beta spectrum defined by Eckerman [76] in a 5x5x5 cm block
of liver tissue [77]. An electron/photon-coupled transport simulation of primary
73
CHAPTER 4. CT-BASED MICROSPHERE DETECTION
and secondary particles was performed with an energy cutoff of 1 keV and a re-
duced electron step-size to limit inaccuracies related to the condensed history
approximation.
The figure of merit for stage III was chosen to be the mean absolute error
(MAE) between the voxels of the true and estimated dose maps. This figure
of merit provided an appropriate penalty for FNs and FPs in each region, be-
cause missing or erroneously added microspheres contributed to the error in
the same manner as incorrectly located spheres. Given that the optical micro-
graph only provided two-dimensional sphere location data, the dose from the
optically determined locations was compared to that of the three-dimensional
localized points by assuming the true points were all co-planar, projecting the
estimated points into that same plane and comparing the resulting dose maps.
The time-integrated activity map varied slightly based on the choice of the
activity map origin relative to the microsphere coordinates due to discretiza-
tion effects. Thus, the average relative MAE between the true and estimated
dose maps was calculated over 100 trials with the dose maps shifted by a ran-
dom amount in each dimension. The error due only to the sphere localization
stage was estimated by measuring the MAE between the true dose map and
a map created with location estimates found using the detected regions and
the correct number of microspheres. Projecting 3D locations into a single plane
could hide errors that would be present if the true 3D microsphere locations
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were known and used for the dose MAE. Because of this, the percent reduc-
tion in dose MAE observed when reducing dimensionality was estimated by
projecting the two-dimensional microsphere locations along different vectors
into a single dimension and calculating the relative dose distribution errors.
Finally, the stability of microsphere locations estimated using the weighted k-
means clustering algorithm was studied by performing 100 trials with different
initial random seeds and evaluating the variation in dose distribution error.
This algorithm’s suitability for characterizing microsphere clusters in scanned
samples was evaluated by comparing the histograms of the true and estimated
microsphere cluster sizes, where clusters were determined using single-linkage
clustering with an inter-cluster distance cutoff of 200 µm, as done by Högberg
et al. [51].
4.2.5 Patient specimen
To illustrate the utility of these methods, the method was applied to an archived
pathology specimen from a patient with an 8x5x5 cm neuroendocrine tumor in
the right hepatic lobe, treated with 90Y glass microspheres 10 days after mi-
crosphere calibration. The patient received a liver transplant for cirrhotic liver
failure approximately 2 years after RE, at which time the specimen was ob-
tained. Following automated microsphere identification, microdosimetry was
performed on the sample which was approximately 2x1x1 cm in size.
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4.3 Results
4.3.1 Phantom preparation and imaging
A careful examination of the optical micrograph revealed 1,434 microspheres in
phantom 1 and 1,697 microspheres in phantom 2. The phantoms were scanned
using micro-CT imaging and an example slice is shown in figure 4.2.
4.3.2 Detection and localization algorithm development
and verification
The detection and localization algorithm was applied to the three-dimensional
CT image in the sequence of stages described above. Those stages are illus-
trated in figure 4.3 using a small area of phantom 1. Parts 4.3c-4.3e demon-
strate the thresholding, area filtering, and dilation operations of region detec-
tion, parts 4.3f-4.3g exemplify the estimation of microsphere quantities during
the sphere quantification stage, and 4.3h shows circles estimated during the
localization stage overlaying the true microsphere locations.
Due to clear shifting of the agar and microspheres near the phantom edges
due to agar desiccation and gravity effects in the hours before and during the
CT scan, spheres and detected regions located in the periphery of the phantom
were excluded, as shown in figure 4.4, to allow the algorithm performance to be
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Figure 4.2: A single slice of the phantom CT scan showing (i) several stacked
phantoms, (ii) the Parafilm wrapping, (iii) a small syringe filled with formalin,
(iv) and a small syringe filled with water.
characterized independent of motion in the phantom. After excluding periph-
eral areas, 980 microspheres remained in phantom 1 and 1,555 microspheres
remained in phantom 2 and were used to calculate the performance metrics.
4.3.3 Performance evaluation
Figure 4.5 shows the fraction of microspheres detected and the fraction of re-
gions containing microspheres after region detection as a function of the detec-
tion threshold, dilation radius, and minimum sub-region volume. The fraction
of microspheres detected remained fairly constant for a wide range of detection
thresholds (dropping from 1.000 to 0.893 over the range 460 to 1700 HU above
background), minimum sub-region volume (dropping from 1 to 0.990 over the
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(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 4.3: A visual representation of the three-stage process used to detect
microspheres. (a) An optical scan of a region containing microspheres is used
to determine gold-standard microsphere locations. (b) The region is scanned
using micro-CT, displayed here as a MIP of the CT image. (c) Regions are
detected by retaining only voxels above the detection threshold. (d) Regions
much smaller than the average microsphere volume are then removed, leaving
the detected sub-regions. (e) Voxels around those sub-regions are also consid-
ered during quantification. (f, g) The CT values in the regions are summed to
determine the quantities of spheres present in each region. (h) Finally, local-
ization estimates microsphere locations using the region detection and sphere
quantification outputs.
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(a) (b) (c) (d)
Figure 4.4: (a) An optical micrograph of phantom 1, including areas exhibiting
motion discrepancies. (b) The area of phantom 1 free from obvious motion
artifacts. (c) A detailed view of an area exhibiting motion marked in parts (a)
and (b). (d) MIP of the corresponding area in the longer-exposure CT image
taken 16 hours later. Note that the bright areas in the top right show less
evidence of motion and usually correspond to spheres in the optical image. The
bottom left section contains distorted, non-compact bright regions that do not
correspond to the optical image due to motion.
range 0 to 120 voxels), and dilation radii (remaining constant at 1 for radii from
0 µm to 131.2 µm). The fraction of regions containing microspheres varied more
as parameters changed. Using detection thresholds below 668 HU resulted in
many regions without microspheres, but fewer than 1.5% of detected regions
contained no microspheres for thresholds between 668 and 1700 HU. Similarly,
if no minimum sub-region volume filter was employed, thousands of spurious
regions were found, but ignoring sub-regions smaller than 25 voxels reduced
the number of spurious regions to 16. Increasing the dilation radius also in-
creased the fraction of regions with spheres by merging spurious regions with
nearby regions containing spheres; the fraction containing spheres was above
97.4% for the range of radii studied.
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(a) (b) (c)
Figure 4.5: (a) Region detection performance as a function of threshold. (b)
Performance as the minimum detected sub-region volume increased. (c) Per-
formance as the dilation radius increased. Region detection performance was
fairly consistent for large ranges of each parameter. Except when acting as the
independent variable, the detection threshold was 668 HU over background,
the minimum sub-region volume was 25 voxels, and the dilation radius was
17.5 µm.
Figure 4.6 shows the values of the stage II quantification metrics, the TPF,
FPF, and difference between them, for both methods of sphere quantification
for the same stage I parameter ranges. Results shown in the top row are for
the WBG method, which assumed that region volume scaled linearly with the
number of spheres present; the bottom row are for the NBG method, which did
not make this assumption. The plots in figure 4.6 also show the 95% confidence
interval of detection performance to illustrate the sensitivity of quantification
performance to the particular regions used to estimate the number of micro-
spheres in each region. Higher detection thresholds affected the TPF of the
WBG method more strongly than it affected the TPF of the NBG method. How-
ever, because the NBG method performed best without area filtering and with
large dilation radii, lower thresholds caused all microspheres to be detected in
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a single region, which did not permit a robust estimate of ζ̂ . The WBG TPF
peaked at 460 HU above background and dropped from 94.9% to 78.4% while
the NBG TPF varied narrowly between 94.3% and 95.7% above 771 HU. The
FPF of the NBG method was much higher for the lowest detection thresholds
used, but for thresholds higher than 875 HU the FPFs of both methods were
within 5 percentage points. The WBG method TPF performance was more con-
sistent as the minimum volume changed, while the NBG method decreased
from 88.2% to 74.8%. The FPF as the minimum volume changed remained es-
sentially the same for both methods, neither varying more than 2 percentage
points, Quantification performance was most sensitive to dilation radius. For
the WBG method, the difference in TPF and FPF was maximized when includ-
ing voxels within 17.5 µm of the sub-region. Including pixels beyond 17.5 µm
resulted in slightly worse TPF performance and markedly worse FPF perfor-
mance. Further, the 95% confidence interval of the difference between the TPF
and FPF widened from 2.8% at the optimal dilation radius to 35.3% for larger
radii. For the NBG method, the difference between TPF and FPF was maxi-
mized when the dilation radius was 79 µm. The 95% confidence interval for the
NBG method was similar to the WBG method. The interval was approximately
3.0% at the optimal dilation radius, and for larger radii it increased to 12.5%.
The best overall performance was achieved using the WBG method with a
detection threshold of 668 HU above background, a minimum sub-region vol-
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(a) (b) (c)
(d) (e) (f)
Figure 4.6: (a) (b) (c): Performance when quantifying microspheres using
the WBG (region values including background) method. Unless acting as the
independent variable, the detection threshold was 668 HU over background,
the minimum sub-region volume was 25 voxels, and the dilation radius was
17.5 µm. (d) (e) (f): Quantification performance using the NBG (region values
above background) method. Unless acting as the independent variable, the
detection threshold was 1,082 HU over background, the minimum sub-region
volume was 0 voxels, and the dilation radius was 78.7 µm. These default param-
eters were chosen to produce best results for each method. For both methods,
(a) and (d) compare performance as a function of the detection threshold, (b)
and (e) show performance as a function of the minimum sub-region volume,
and (c) and (f) compare performance as a function of dilation radius. Quan-
tification performance was more sensitive than region detection performance
to the values chosen for each parameter. The 95% confidence intervals for
each measurement are shown, illustrating the sensitivity of each method to
the measurements used for estimation. The NBG performance for thresholds
below 771 HU has good average performance because the low thresholds and
large dilation radius produce 7 regions, 6 of which are spurious, and 1 that con-
tains all microspheres, but more regions are necessary to estimate ζ̂ without
over-fitting. From 771 HU to 1700 HU the number of regions detected varies
between 278 and 1,668, which does allow ζ̂ to be estimated. Similar issues
do not occur at the same threshold with the WBG method due to the smaller
dilation radius.
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ume of 25 voxels, and a dilation radius of 17.5 µm. In phantom 1, 464 regions
were detected, of which 439 contained 980 microspheres. The quantification
scalar, ζ , was estimated to be 2.8 · 104 HU per microsphere. Using this scalar
during microsphere quantification correctly estimated that 13 of the remain-
ing 25 regions had no microspheres. The proposed algorithm estimated that
there were 1,017 microspheres in the phantom (95% confidence interval of 976
to 1056 microspheres), giving an error of 3.8% (confidence interval -0.4%-7.8%).
When the parameters were applied to phantom 2, 453 regions were detected,
448 of which contained 1,553 microspheres. The proposed algorithm estimated
there were 1,532 microspheres in the phantom, giving an error of 1.5%. When
applied to phantom 2, the quantification stage had a TPF of 93.8% and a FPF
of 4.8%.
Sphere localization was performed on the output of the WBG quantification
stage applied to phantom 2 using the different localization methods described
above. The relative MAE between the dose maps of the true and estimated
microsphere locations, averaged over 100 trials with randomly shifted origins,
is shown for each localization method in figure 4.7. Using k-means clustering
on the voxels in each detected sub-region best approximated the microsphere
locations, giving the lowest absolute dose distribution error of 4.2% (about 5.0
Gy for a 120 Gy treatment). The average relative MAE between the true dose
and that estimated using the best localization method and the correct number
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of microspheres for each region had a relative error of 1.6% (about 1.9 Gy for
a 120 Gy treatment) and is also shown in figure 4.7. Projecting the estimated
microsphere locations into a single dimension prior to measuring the relative
dose distribution error reduced the error to about 2.6% for all stages, or 0.98%
when given correct microsphere quantities. The mean relative dose distribu-
tion error from 100 k-means localization trials was 4.2±0.11%.
Figure 4.7: A comparison of the relative MAE of the different proposed micro-
sphere localization methods applied to phantom 2 processed with optimal pa-
rameter values. The upper value on each bar is the MAE of the full algorithm
using the regions detected in stage I and the number of microspheres estimated
in stage II, and the lower value is the MAE of just the localization stage using
the regions detected in stage I and the correct number of microspheres in those
regions. The worst-performing localization methods performed worse when the
correct number of microspheres were localized due to the likelihood of misplac-
ing more microspheres. The more accurate methods improved when the correct
microsphere counts were used. The lowest-error localization method used the
centroids of the clusters detected using k-means clustering on the detected sub-
region voxels with weightings based on the voxel values. Most of the error for
k-means-based localization was due to inaccuracies in the number of micro-
spheres in each region.
Figure 4.8 compares the frequency of clusters of different sizes for the true
microsphere locations and those estimated via the full method presented here
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with a bin size of 3.
Figure 4.8: A comparison of the histograms of detected and true microsphere
clusters formed via single-linkage clustering with a 200 µm inter-microsphere
distance cutoff.
4.3.4 Patient specimen
A total of 7,671 microspheres were detected in the human tissue sample. The
spheres aggregated into 1051 clusters (defined as groups of spheres separated
by at least 200 µm). Figure 4.9 shows a visualization of the detected micro-
spheres within the tissue sample, the corresponding dose map, and a detail
view indicating that the detected microspheres organize into linear 3D pat-
terns as the microspheres fill vessels. Figure 4.9b shows the highly heteroge-
neous pattern of absorbed dose deposition where 40% of this section of tumor
tissue received < 20 Gy (V20 = 60) while areas with dense sphere deposition
received over 3000 Gy.
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(a) (b)
(c)
Figure 4.9: (a) A visualization of the microspheres in a tissue sample of a
neuroendocrine tumor treated with glass microspheres prior to resection. (b) A
MIP of the dose map corresponding to the detected microsphere locations. (c)
A detailed view of the sample center that shows the vessel-like shapes of some
of the detected microsphere clusters.
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4.4 Discussion
The performance of region detection was most strongly correlated with the de-
tection threshold. Varying the minimum volume and dilation radii had only
modest impacts on both the fraction of microspheres contained in regions and
the fraction of regions that were spurious. The range of useful parameters was
narrowed by considering the impact of region detection parameter choices on
later stages.
Most of the final error in detection and localization was due to the sphere
quantification stage. Figure 4.6 demonstrated that the best results were found
using the WBG method with a relatively low detection threshold and a small
dilation radius. Few voxels outside of those occupied by microspheres were in-
cluded when a small dilation radius was used, which improved the accuracy of
the approximation on which WBG depended, vR ≈ n · vR1. Conversely, the NBG
method performed best with a larger dilation radius because it didn’t explic-
itly depend on the volume of the region. Examining fewer voxels can make
the method more sensitive to noise, as the effects of noise on the integrated
intensity of larger regions is more likely to balance out. The potential sensi-
tivity of the WBG method to noise is important to consider because in a large
tissue sample the noise is expected to be higher than in the thin phantoms
used in this work. The WBG method is also more sensitive to artifacts that are
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only partially mitigated, such as the attempted ring correction shown in figure
4.10. If the voxels neighboring the detected sub-region are included in the inte-
grated intensity then the excessively bright and dark voxels will tend to cancel
out, but if the region is too small then false positive microsphere locations will
be estimated.
There are some benefits to using a small dilation radius, however. If the
background medium is non-uniform, a smaller dilation radius can make quan-
tification more robust by mainly including voxels overlapping microspheres.
For example, if microspheres are trapped in a tissue sample with regions of
air, then both quantification and localization can be affected due to parts of
the region contributing much less than expected to the integrated intensity. If
very few voxels containing background are included, then the contribution of
unexpected pixel values will still be small relative to the overall region sum.
Thus, while the best overall performance with these phantoms was achieved
using the WBG method, the different strengths of each method merit consid-
eration when deciding which method to use for quantification. Interestingly,
Marxen et al. described an algorithm for sphere quantification that appears
very similar to the WBG method, though they reported a higher FPF, possibly
due to not being able to filter spurious regions due to similar microsphere and
CT voxel sizes [47].
The MAE between the true and estimated dose maps was relatively small,
88
CHAPTER 4. CT-BASED MICROSPHERE DETECTION
(a) (b)
(c) (d)
Figure 4.10: A comparison showing how each quantification method dealt
with an incorrectly mitigated streak artifact. (a) A streak artifact in one slice
of the CT image. Note that the very bright voxels were accompanied by very
dark voxels. (b) A MIP of the region that was correctly determined to have no
microspheres by the NBG method. (c) A MIP of the region that was incorrectly
determined to have 3 microspheres by the WBG method. (d) The corresponding
area of the optical image where WBG estimated 3 microspheres were present.
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and a majority of that error arose due to errors in stage II. Given that those val-
ues do not include the error due to incorrect localization in the direction normal
to the microsphere plane, it is likely that the true MAE is slightly larger. Re-
ducing the dimensionality of the dose map reduced the dose distribution error
by less than two percentage points, which suggests that the error due to incor-
rect localization in a single dimension had a fairly minor effect on the overall
accuracy.
Fairly evaluating the method requires dealing with limitations inherent to
the phantom. As noted in figure 4.4, the microspheres in the phantom periph-
ery shifted, which was mitigated by excluding the periphery. While periph-
eral motion due to agar desiccation and contraction was fairly obvious, there
may also have been microsphere motion within detected regions that could only
have been observed by optically scanning the phantom before and after the CT
scan. A better way to prevent motion would be to use a background medium
that cures, is optically transparent, and has a similar attenuation coefficient
to tissue, such as the epoxy used by Marxen et al. [47]. If concerns about mi-
crosphere motion were fully addressed, then acquisition parameters could be
changed to improve detection. For example, when the phantom was scanned
with twice the exposure time to reduce noise in detected phantom regions, the
number of spurious regions was reduced, but overall accuracy suffered due to
more microsphere motion during the longer scan. If a scan that just reduced
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noise without increased motion were used, it could potentially improve micro-
sphere quantification results, which account for most of the dose distribution
error observed in the method.
Another potential source of errors in the phantom is bubbles in the agar.
Some large bubbles are visible in figure 4.4c, but bubbles around the same
size as the microspheres are harder to distinguish from spheres in the optical
microscope image. Examples of this are shown in figure 4.11. It is possible that
different background materials would not have the same issue with bubbles as
agar. If that is not the case, then a high-resolution x-ray image of the phantom
could be used to identify hard-to-discern bubbles and improve the evaluation
of algorithm performance.
4.4.1 Transition to tissue specimen
The single example tissue specimen detailed in figure 4.9 elucidates the new
information that may be realized with this method. Archived tissue specimens
from tumor and normal liver tissue in patients that have received 90Y RE and
subsequent liver transplant are plentiful at transplant centers [78], and the
described method for non-destructively mapping the 3D microscopic distribu-
tion of microspheres using micro-CT may be key for future understanding of
the radiobiologic effects of RE. However, additional work outside the scope of
this manuscript may still be required for accurate microdosimetric evaluation
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(a) (b)
Figure 4.11: (a) An example of a difficult-to-distinguish bubble in the agar
phantom. The central circular shape differed in appearance from the 7 micro-
spheres surrounding it. (b) An example of questionable microspheres. These
were marked as true microspheres, but the strange shapes of one or more
spheres surrounding the largest, central microsphere suggest that some of the
displayed spheres may have actually been microsphere-sized air bubbles.
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in tissue samples including: accounting for lack of charged particle equilibrium
at tissue boundaries, sphere movement between treatment and explantation of
liver tissue, and tissue volume changes during tissue fixation and preservation.
4.5 Conclusions
This work presented a method for studying 3D glass microsphere distribution
in large, unsectioned tissue blocks. The method is based on the combination
of high-resolution micro-CT scans of the sample and a multi-stage algorithm
that detects regions containing microspheres, estimates the number of micro-
spheres in each region, and estimates the location of each sphere within the
scanned block. This algorithm was validated by scanning a phantom with
known microsphere locations and comparing the dose map generated using the
estimated locations to the true dose map. The algorithm’s utility was demon-
strated by detecting microsphere locations and estimating the dose map for a
human tissue sample of a neuroendocrine tumor that was treated with glass
microspheres prior to excision.
This method can be used to detect microsphere quantities and locations
with accuracies that far exceed what is possible using state-of-the-art PET
scans [79] using a less time- and labor-intensive process than sectioning, stain-
ing, and optical scanning. The ability to more simply and accurately calculate
dose and detect microsphere clustering in larger tissue sections could yield im-
93
CHAPTER 4. CT-BASED MICROSPHERE DETECTION
portant insights on how glass microspheres cluster in normal and tumorous
tissue and improve radioembolization treatment planning.
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The ability of the HAT generation method and the particle transport and trap-
ping method described in chapter 3 to predict the risk of toxicity in normal liver
tissue depends on the accuracy of the simulated distribution of microsphere
cluster sizes. Walrand et al. simulated a microsphere distribution and showed
that, when used with their proposed radiobiologic model, it produced reason-
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able predictions for the survival of normal liver tissue. A critical aspect of their
results was that a sufficiently heterogeneous dose distribution would spare lob-
ule structures frequently enough that surviving lobules could compensate for
the damaged or dead lobules. The heterogeneity of the dose distribution is di-
rectly impacted by the clustering behavior of the microspheres. However, like
the work presented in chapter 3, clusters of that simulated distribution were
not verified to be physically realistic [10,11].
Högberg et al. carefully measured the clustering behavior of resin micro-
spheres in several samples of normal human liver tissue and used that infor-
mation to propose a novel trapping model that produced clusters consistent
with their observations [51, 70]. This method modeled the HAT as a balanced
binary tree, which differed substantially from the branching structures ob-
served in true liver vasculature. Also, there are several notable differences be-
tween resin and glass microspheres, including differences in size distribution,
density, specific activity, and in the total number of microspheres used in treat-
ment [19]. Furthermore, resin microspheres, unlike glass microspheres, ag-
gregate when suspended in a saline solution [19]. A typical resin microsphere
treatment contains between 20 and 60 million spheres, while glass microsphere
treatments usually administer less than 2 million spheres [30]. Kennedy et al.
compared glass and resin microsphere distributions qualitatively and did not
observe notable differences [69], but given the different administered quanti-
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ties there must either be a difference in the total number of clusters or in the
number of microspheres contained in those clusters [51]. This suggests that
clustering information from resin-microsphere treatments cannot be directly
used to predict glass microsphere clustering behavior.
To understand the risk of toxicity for treatments of glass microspheres, a
characterization of glass microsphere clustering is necessary. Chapter 4 dis-
cussed a novel method to characterize glass microsphere distributions in whole
tissue samples using micro-CT. Applying that method to large, treated porcine
liver samples should allow characterization of a large number of microspheres
in treated tissue, and comparison with simulated microsphere clustering.
5.2 Materials and methods
The use of animals in this work was performed under IACUC approval.
To verify the clustering behavior in the microsphere distributions simulated
using the HAT model from chapter 3, it is necessary to examine microsphere
distributions in normal liver tissue. Due to the similarity of the vascular struc-
ture of porcine and human livers [80] and a dearth of preserved normal human
liver tissue samples, a characterization of the microsphere distribution in a
normal porcine liver was attempted for this work.
97
CHAPTER 5. COMPARISON OF MICROSPHERE DISTRIBUTIONS
5.2.1 Treated porcine liver sample
An approximately 321 MBq TheraSphere treatment was administered to a ju-
venile pig 292 hours after calibration time, which corresponded to a whole-liver
dose of 53 Gy. After administration, the pig was maintained alive for several
weeks to observe complications due to treatment before the pig was sacrificed
and the liver was explanted and stored in Formalin prior to imaging.
The liver was divided into two equally sized pieces and imaged using a
Bruker SkyScan 1176 micro-CT scanner (Bruker MicroCT, Kontich, Belgium).
The scanner allowed large samples to be imaged at high resolution by mov-
ing the scanner bed. The approximate dimensions of each imaged liver piece
was 5x5x11 cm. A total of 708 projections were acquired for each bed position
at a tube voltage of 80 kVp and an exposure of 1.8 mAs. Other relevant scan
parameters were unchanged and are described in chapter 4.
After imaging the liver samples, microsphere locations in one sample were
estimated using an algorithm based on the NBG method described in chapter 4.
Because the sample was much larger than the phantoms scanned in chapter 4,
the background variance was expected to be significantly higher and required
a different set of region detection parameters to reduce the expected number of
FPs.
To review the relevant portion of chapter 4 briefly, the process of estimating
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parameters and measuring detection method performance was done using thin
phantoms composed of glass microspheres embedded in agar and sandwiched
between two coverslips. These were scanned using a high-resolution optical
microscopy to determine the true microsphere locations, and then scanned in
the same micro-CT system used for the liver slices. The region-detection stage
of the microsphere detection algorithm was applied to the first phantom to
estimate ζ̂ , the scalar used in the NBG method to relate the sum of the voxels
identified during region detection to the number of microspheres found in those
regions. The same detection parameters and the estimated scalar were then
applied to a second phantom in order to find regions, estimate microsphere
quantities in those regions, and measure the performance of the microsphere
detection algorithm.
Experience with the phantoms showed that microspheres were generally
easy to identify visually. Using the parameters that worked best for the thin
phantoms and tissue specimens on the large liver samples identified areas that
did not appear to contain microspheres. Higher thresholds and larger mini-
mum regions were tested with the phantoms, and values that produced the
best visual results in the livers while maintaining acceptable TPFs and FPFs
using the phantoms were used for the analysis. After microsphere quantities
were estimated in regions of the porcine liver, microsphere locations were esti-
mated using the weighted k-means algorithm described in chapter 4.
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After microsphere locations were estimated, the locations were partitioned
into clusters by grouping detected microspheres that were closer than 200 µm.
5.2.2 Microsphere transport model
With the microsphere distribution characterized as described above, it was
then possible to verify the clustering behavior of simulated microsphere distri-
butions created using a variety of microsphere infusion models. These methods
were based on the simulated particle transport model described by Walrand et
al. [10]. All methods modeled particle infusion as a process where a single mi-
crosphere was placed in an initial vessel and was carried through the tree until
the microsphere arrived at a trapping vessel. When the microsphere encoun-
tered a bifurcation, it randomly entered one child vessel or the other proba-
bilistically. The probability of a microsphere entering either vessel depended
not only on the relative flow of blood in the two branches, but on the vessel
geometry. This combined dependence on both flow and geometry was based on
work by Kennedy et al. that used fluid dynamics simulations of microspheres
traversing a two-generation vessel tree. Each of the four output vessels had
equal blood flow, but the flow of microspheres through the children vessels was
nevertheless unequal due to differences in vessel geometry. Walrand et al. as-
sumed that microspheres were slightly more likely to enter the child vessel
most aligned with the parent vessel (referred to as the straighter vessel) and
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less likely to enter the less-aligned vessel (referred to as the more bifurcating
vessel). They then showed that images produced with that assumption were
more heterogeneous and more qualitatively similar to microsphere distribu-
tions observed in vivo with PET imaging. The probability of a microsphere





Ps = 1−Pb, (5.2)
where Pb and Ps are the probabilities of the microsphere entering the more bi-
furcating and the straighter vessel, respectively, Db is the ratio of blood flow
through the more bifurcating vessel and the parent flow, and p is the proba-
bility of a sphere entering the more bifurcating vessel for equal child outflow.
Based on Kennedy’s work, Walrand chose p = 0.4.
Using this general framework, the infusion methods investigated in this
work can be classified by their handling of two orthogonal concepts: embolic
(EM) versus non-embolic (NE) methods and diameter-aware (DA) versus diameter-
unaware (DU) methods. Embolic methods assume that the trapping of micro-
spheres in vessels inhibits the flow of blood in that vessel and parent vessels,
while non-embolic methods assume that blood flow is unchanged regardless of
how many microspheres trap in a vessel. The change in flow to each vessel
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requires Pb and Ps to be updated for all vessels in the tree after a microsphere
traps, and generally reduces the maximum number of microspheres found in
trapping vessels due to the reduced likelihood of microspheres reaching each
one. Non-embolic infusion methods do not adjust the flow as microspheres trap,
which increases the maximum number of microspheres that cluster in trapping
vessels.
Another aspect of infusion models is if the diameters of microspheres and
the vessels through which they flow are considered when determining trap-
ping locations. Diameter-unaware methods assume that all microspheres trap
in THAs, regardless of the diameters of the microspheres and vessels involved,
while diameter-aware infusion models trap microspheres in higher-order ves-
sels if child vessels are too narrow to admit the microsphere. When a micro-
sphere arrives at a bifurcation in a diameter-aware method, it is trapped if the
microsphere diameter exceeds both children vessel diameters (or if a larger mi-
crosphere is already trapped there), it enters the larger vessel if only one vessel
diameter is smaller than the microsphere, and it enters either vessel randomly,
as described by (5.1) and (5.2), if both vessels are large enough to admit the
microsphere. Restricting microsphere flow based on vessel and microsphere
diameters effectively reduces the number of potential trapping locations.
A model of the HAT was generated as described in chapter 3, and ten
microsphere distributions were simulated within that tree for each combina-
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tion of infusion methods described above, specifically diameter-unaware, non-
embolizing (DU-NE), diameter-unaware, embolizing (DU-EM), diameter-aware,
non-embolizing (DA-NE), and diameter-aware, embolizing (DA-EM) infusion
simulations. The same cluster analysis was performed on the simulated mi-
crosphere locations as the micro-CT image, where microspheres within 200 µm
of other microspheres were grouped into the same cluster. The number of mi-
crospheres used for each simulated infusion was proportional to the number-
density of microspheres in the porcine liver, but scaled to the XCAT liver vol-
ume.
The distribution of cluster sizes was then compared between the 4 simu-
lated methods and the detected clusters from the porcine livers to determine
which simulation method produced the most realistic clusters. Due to the large
number of microspheres in the simulation, attempts to directly perform single-
linkage clustering failed due to lack of memory. However, as portal tracts are
spaced at least 600 µm apart, it is possible to approximate cluster sizes by it-
eratively grouping vessels with microspheres through shared parent vessels,
provided the distance between spheres in child and parent vessels doesn’t ex-
ceed 200 µm. Images with resolution similar to that of 90Y PET were also simu-
lated, as explained in chapter 3, by generating a volume image with 2 mm pixel
widths and convolving it with a 3-dimensional Gaussian filter with FWHM
8 mm. A single coronal slice from near the center of the volume was extracted
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from a representative microsphere distribution for each microsphere transport
model described above.
5.3 Results
5.3.1 Treated porcine liver sample
A representative liver sample that has been prepared for micro-CT imaging is
shown in figure 5.1.
A slice of the micro-CT image of the liver sample is shown in figure 5.2.
Several clusters of microspheres are clearly visible.
The parameters for region detection and sphere quantification were chosen,
and their performance was verified, using the phantoms from chapter 4. Re-
gions with more than 25 connected voxels that were at least 2,000 HU above
background were identified as regions of interest, and ζ̂ from the NBG method
was estimated to be 1.68 ·10−6 spheres per HU using one of the phantoms and
a dilation radius of 3. Performance was estimated using these values in a dif-
ferent phantom. In that phantom, regions were detected that contained 83%
of microspheres, and quantification in those regions resulted in a TPF of 0.74
and a FPF of 0.036.
The liver sample was then processed with those same parameters, and it
was estimated that 838,102 microspheres were present in 128,877 separate
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Figure 5.1: An example of a treated and resected porcine liver that has been
divided to allow it to be imaged with a high-resolution micro-CT scanner.
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Figure 5.2: A slice from a micro-CT image of a 144 mL porcine liver sam-
ple that received an approximately 53 Gy glass microsphere treatment. Bright
spots in the object are generally clusters of one or more microspheres.
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clusters. A representative area of the tissue sample is displayed in figure
5.3. Based on a segmentation of the micro-CT image, this gave a microsphere
number-density of approximately 5,820 microspheres per mL of liver. A his-
togram of the cluster distribution with a bin width of 10 spheres is shown in
figure 5.4.
Figure 5.3: A representative section of the locations estimated by the micro-
sphere detection algorithm when applied to the porcine liver image. Note the
highly heterogeneous pattern; while many microspheres appear isolated, many
are aggregated into clusters.
5.3.2 Microsphere transport model
The simulated HAT contained 1,849,267 portal tracts, which translated to
roughly 4.8 million THAs with an average diameter of about 13 µm for a physi-
cally realistic blood flow of 400 mL/min. The tree also contained approximately
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Figure 5.4: A log-scaled histogram of the incidence of clusters of different sizes
per mL in a 144 mL porcine liver sample, aggregated into bins of 10 elements.
550,000 vessels greater than the average TheraSphere diameter that either
had no child vessels, or had only children vessels smaller than the average
sphere diameter (i.e., potential trapping vessels). That tree is shown in figure
5.5.
A cluster-size histogram, created from the 10 simulated infusions for each
model, is displayed in figure 5.6. All microsphere-infusion models produce clus-
ter distributions that predominantly have single-spheres, but diameter-aware
methods more frequently contain larger clusters, resulting in a histogram with
a longer tail. This is reflected in the maximum cluster size for each method. For
the DU-NE method it is 111 spheres, for DU-EM it is 50 spheres, for DA-NE it
is 339 spheres, and for DA-EM it is 64 spheres.
The same slice of a simulated activity image at PET resolution was gener-
ated using each infusion model and is shown in figure 5.7.
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Figure 5.5: The hepatic arterial tree used for microsphere infusion simula-
tions. It contains approximately 1.8 million portal tracts and the average ter-
minal hepatic arteriole is 13 µm.
Figure 5.6: A log-scaled histogram comparing the frequency per mL of clus-
ters using the diameter-unaware non-embolizing (DU-NE), diameter-unaware
embolizing (DU-EM), diameter-aware non-embolizing (DA-NE), and diameter-
aware embolizing (DA-EM) methods.
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(a) DU-NE (b) DU-EM
(c) DA-NE (d) DA-EM
Figure 5.7: Representative slices of simulated dose images generated using
the four microsphere infusion methods described in this work. Non-embolic
methods are always more heterogeneous than embolic methods, but diameter
awareness has a more complicated effect on distribution heterogeneity. If the
method is non-embolic, diameter awareness increases heterogeneity, but for
embolic methods it has the opposite effect.
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5.4 Discussion
This work shows that microspheres within normal porcine liver tissue aggre-
gate into much larger clusters than predicted by previous models of micro-
sphere infusion and trapping [10, 68]. Thus, trapping models that result in
larger clusters like those observed in the liver sample likely produce more re-
alistic micro-scale dose distributions that could be a useful predictor of normal
liver tissue toxicity for different treatment plans.
The greater noise present in large tissue samples resulted in larger FPFs
than were observed in the thin phantoms used to verify this method. That ne-
cessitated a much higher detection threshold, which likely increased the FN
count. While the FN increase can be estimated using phantom data, the in-
crease in FPs is more difficult to predict. Thus, while chapter 4 demonstrated
that glass microspheres can be detected with high accuracy and few false pos-
itives in both thin phantoms and reasonably thin tissue samples (around 1
cm), more work is necessary to fully understand algorithm performance in the
presence of noise observed in larger tissue samples.
However, it was observed using the phantom that nearly all FNs were iso-
lated microspheres, and at lower thresholds, spurious regions caused by noise
were almost all estimated to have fewer than two microspheres. In larger clus-
ters, misestimations of only one or two microspheres per cluster were observed.
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This suggests that, in spite of noise, the very large clusters observed in this
work are representative of actual microsphere clustering behavior, and thus
accurate particle transport and trapping simulations must produce similarly
large clusters. Further evidence supporting this fact is that the total activity
of the microspheres infused into the pig is consistent with the number-density
of microspheres detected in this work.
Of the different distribution methods tested above, the DA-NE method pro-
duced the most realistic distributions of microspheres at the number-density
observed in the porcine liver sample. Figure 5.6 shows that the embolizing
methods seldom had clusters larger than 50 spheres (the maximum allowed in
a THA), while the DA-NE infusion method produced larger clusters. Walrand
observed that modeling embolic effects tended to create a less heterogeneous
distribution of microspheres [10]. This was also observed using the infusion
models in this work.
However, diameter awareness when determining trapping locations had a
more complicated effect on cluster sizes and the heterogeneity of the images
shown in figure 5.7. If embolic effects were being modeled, then the micro-
spheres were more evenly spread among a smaller set of trapping locations,
which reduced heterogeneity, as shown in 5.7d. However, figure 5.7c shows
that diameter awareness without modeling embolic effects on blood flow in-
creased the heterogeneity, as microspheres that might have formed clusters
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downstream of a narrow vessel instead formed one large cluster in a higher-
order vessel.
The improved accuracy of non-embolizing methods was unexpected, as the
embolizing method discussed by Walrand et al. seemed like a more realistic
model of particle infusion and trapping due to its simulation of decreasing blood
flow as microspheres trap. However, these results suggest that non-embolizing
methods may be a more accurate model of the infusion process, and given that
glass microspheres are injected in a single bolus [48], microsphere traversal of
the vessel tree is likely not substantially impacted by flow changes between the
trapping of different microspheres.
There are still important differences between the true and simulated cluster
distributions. For example, the relative incidence of small cluster sizes is much
higher with all simulated distributions, and even the DA-NE model produces
far fewer large clusters than observed in reality. This suggests that models
of microsphere trapping that result in even larger clusters may produce more
realistic distributions.
5.5 Conclusions
The accuracy of microsphere distributions simulated in this work is impor-
tant for predicting the likelihood of toxicity in normal liver tissue treated with
glass microspheres. Using micro-CT imaging of a large treated liver sample,
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this showed that microsphere clusters found in normal porcine liver tissue had
larger cluster sizes than predicted by previous simulation methods. A new
model of particle transport and trapping was proposed and shown to produce
more realistic clusters. More accurate simulation of microsphere distributions
would provide more accurate estimates of the dose distribution in the liver.
This would allow comparing different treatment plans, such as varying num-
bers of microspheres with different activities per microsphere, through simula-
tion, which could lead to improved treatment planning and patient outcomes.
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Summary and Future Work
6.1 Summary
The incidence of liver cancers is increasing worldwide, and better treatment
options are necessary to improve patient outcomes. Radioembolization (RE)
is a palliative treatment option that is increasingly used in conjunction with
curative treatments to increase their applicability and effectiveness. Improved
treatment planning has the potential to improve the efficacy of this therapy,
potentially providing curative treatment or increasing the number of patients
qualifying for curative therapies. RE targets liver tumors by inserting millions
of microspheres into the hepatic artery and allowing them to be carried by the
flow until they trap permanently in the vessels and deposit radiation in sur-
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rounding tissues. Those tissues are likely to be tumorous, as tumors in the
liver promote artery growth to access highly oxygenated arterial blood. While
very high absorbed doses to the liver are possible in RE, precisely how nor-
mal liver tissue survives is not well understood. But, there is ample evidence
that tissue survival depends in part on the heterogeneity of the dose, which
in turn depends on the distribution of microspheres within the liver. Non-
uniform microsphere trapping produces a highly heterogeneous dose that may
allow enough normal tissue to survive that sufficient liver function is retained
for the patient to survive the therapy. However, without accurate predictions
of how treatment plans affect toxicity, plans may not deliver a high enough
absorbed dose to tumors to achieve control.
There are a number of variables that can be used to plan therapy, including
the number and activity of the spheres. The ability to model both a patient’s
hepatic arterial vasculature and the flow and trapping of microspheres within
it could enable improved predictions of the probability of liver toxicity and tu-
mor control for different possible treatment plans. Previous work modeling
the hepatic arterial tree has produced models that have physically unrealis-
tic aspects, and simulated microsphere distributions have not been verified
to approximate true microsphere distributions, limiting their utility in under-
standing the radiobiological characteristics of RE therapy and thus treatment
planning.
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Furthermore, three-dimensional cluster analysis of glass microspheres has
not been performed on large sections of normal liver tissue, as traditional meth-
ods for characterizing microsphere locations is time-consuming, manual, and
most commonly performed in two dimensions. Without a representative analy-
sis of glass microspheres in normal liver tissue, attempts to estimate absorbed
doses using computational models cannot be relied upon to provide realistic
dose distributions.
This work has proposed a physically realistic model of the hepatic arterial
tree and models of microsphere transport and trapping that allow the simu-
lation and comparison of RE treatment plans. It has further demonstrated a
novel method to detect, quantify, and estimate the locations of microspheres
within large tissue sections without costly manual processing through the use
of high-resolution micro-CT imaging and automated sphere quantification and
localization algorithms. Finally, it has shown, using cluster analysis, that
different models of microsphere transport varied in their ability to simulate
physically realistic microsphere distributions. This provides data and direc-
tion needed to further refine models of liver vascular anatomy and microsphere
trapping to allow them to be relied upon as tools for improved treatment plan-
ning of RE.
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6.1.1 Hepatic arterial tree model
In order to simulate realistic distributions of microspheres suitable for micro-
scale dose analysis, a major achievement of this work was to generate a phys-
ically realistic, highly detailed model of the hepatic arterial tree. While previ-
ous work had created both a coarse, physically realistic model and a highly de-
tailed, but physically unrealistic model, this work demonstrated how to achieve
both aims.
First, it showed how to create a realistic tree by following three physically
based laws: conservation of matter, which ensured that the amount of blood
flowing into a vessel was the same as the amount flowing out of it; Murray’s
law, which related the diameters of a parent vessel with those of its children
vessels using a bifurcation constant; and Poiseuille’s law, which related the
drop in pressure from the input to the output of a vessel to the vessel’s length,
diameter, and blood flow. This work proposed a method to estimate Murray’s
bifurcation constant using measurable features, such as vessel diameters and
blood pressure. Additionally, the angle at which vessels connected must also be
guided by physically realistic optimization principles. This work chose vessel
connection points that minimized the drag of blood flow on vessel walls, as it
required only local information and research has shown that this factor is an
important influence on vessel branching structure observed in nature.
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The actual tree was generated using a macrocell growth method based on
segmentations of the liver and the hepatic artery taken from the XCAT phan-
tom. The method could be readily applied to liver anatomies and vascular trees
derived from patient data to produce a patient-specific liver model. Macro-
cell growth methods generate realistic vasculature by simulating the growth
of the organ and its vasculature from a small shape to its full size over a se-
ries of cycles. During each cycle, the shape is filled with macrocells that must
be connected to existing vessels. Once the shape is filled and all macrocells
are perfused, the shape is grown, (causing the macrocells to spread apart).
New macrocells are then created to fill the now empty spaces between existing
macrocells.
The hepatic arterial tree models generated using this method were vali-
dated by comparing the derived physical parameters to those reported in liter-
ature. In particular, the terminal hepatic arterioles matched literature values
well, which was important when performing microsphere transport and trap-
ping simulations.
6.1.2 Microsphere detection via micro-CT imaging
While producing physically realistic models of the hepatic arterial tree should
improve the simulation of RE and associated toxicities, if the clustering behav-
ior of a true distribution is unknown, then the accuracy of simulated micro-
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sphere distributions is likewise unknown and cannot be relied upon to provide
useful information for understanding hepatic toxicity or treatment planning.
Traditional methods of assessing microsphere locations and clustering in tis-
sue samples require the samples to be sectioned, stained, scanned, and man-
ually scrutinized in a time-intensive process. Additional care is necessary if
three-dimensional location or clustering information is required. Due to this,
only small tissue samples have typically been examined.
In order to detect and estimate microsphere locations in large tissue sec-
tions more easily, this work developed a novel method using micro-CT imaging
and automated image analysis procedures. This was possible due to the high
attenuation coefficient of glass microspheres compared to normal liver tissue.
The quantification and localization process was implemented in three stages.
First, regions potentially containing microspheres were identified by simply
choosing contiguous voxels having values higher than a particular threshold
value. The sum of those voxels relative to the attenuation coefficient of the
surrounding medium was calculated and used to estimate the number of micro-
spheres present in each detected region. To mitigate the effect of image degrad-
ing factors on quantification, adjoining voxels were also used in the calculation.
Finally, the detected regions and the estimated number of spheres in each re-
gion were used by the localization algorithm to estimate three-dimensional lo-
cations for each microsphere.
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This analysis method was verified by creating very thin phantoms composed
of agar and microspheres that could be scanned by a micro-CT system as well
as by transmission-light microscopy to determine gold-standard microsphere
locations. The scalar relating the integrated intensity above background in a
region to the number of microspheres in that region depended on the thresh-
old, the minimum number of voxels in a region, and on the number of adjoining
voxels used to quantify the microspheres. Thus, the scalar was estimated using
those region detection parameters on one phantom, then the same parameters
and the newly estimated scalar were used on a different phantom to estimate
performance data. Total performance of the method was measured by calcu-
lating the mean absolute error between the dose map created with the true
microsphere locations and the map created with the estimated locations.
The microsphere detection algorithm was then applied to a paraffin-embedded
human tissue sample that had been resected after radioembolization with glass
microspheres. The algorithm performed well, correctly detecting > 93% of em-
bedded microspheres with < 5% of detections being false positives.
After verification, a pig was treated with glass microspheres prior to being
sacrificed and having its liver scanned via micro-CT. The microsphere distribu-
tion in the liver was estimated for one sample that was approximately 5x5x11
cm, and cluster analysis was performed to characterize the estimated locations.
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6.1.3 Microsphere transport and trapping models
The resulting microsphere clustering data from the normal liver tissue samples
allowed different microsphere transport and trapping models to be evaluated.
Previous models simulated microsphere trapping by sending microspheres
from the initial vessel to the randomly selected trapping vessels consecutively.
When the microsphere arrived at a bifurcation, either the straighter or more
bifurcating vessel was chosen based on a combination of the relative blood flow
and the relative geometry of the child vessels. Previous models assumed that
all microspheres trapped in terminal hepatic arterioles, without consideration
of the diameters of the microspheres or intervening vessels. These models dif-
fered in whether a trapped microsphere reduced flow to that vessel or not. If
a trapping model was embolizing, then the blood flowing to an embolized ves-
sel was reduced by some fraction that increased as more particles trapped in
it. This in turn reduced the likelihood of microspheres arriving in that vessel,
with the overall effect that the microsphere distribution was more homoge-
neous. In contrast, non-embolizing methods assumed that blood flow remained
constant, regardless of the number of microspheres present in a vessel. This
tended to create large clusters and an overall less homogeneous microsphere
distribution.
Another aspect of microsphere transport, proposed in this work, is whether
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microspheres always arrive in terminal arterioles, or if they can be trapped
in higher-order vessels within the tree. Most terminal hepatic arterioles are
less than half the diameter of an average microsphere, and thus microspheres
are likely to be trapped in non-terminal arterioles too. Diameter-aware models
consider both the diameter of a microsphere and diameters of the vessels it
passes through as it travels through the vasculature.
Because these concepts are orthogonal, they were combined to create four
different microsphere transport and trapping models: diameter-unaware and
non-embolizing, diameter-unaware and embolizing, diameter-aware and non-
embolizing, and diameter-aware and embolizing.
In order to compare the microsphere clusters formed using each trapping
model, ten microsphere infusion simulations, consisting of approximately 10
million microspheres each, were performed for each trapping model, and clus-
ter analysis was performed on the resulting microsphere distributions. The
number of microspheres simulated was chosen to produce the same micro-
sphere number-density as observed in the porcine sample.
A histogram of the observed microsphere cluster sizes in the porcine sample
showed that while small microsphere cluster sizes were most common, there
were also many large clusters of detected microspheres, several with more than
1,000 spheres. Histograms of the cluster sizes of each transport and trapping
method were also generated, and the method that considered both the diame-
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ters of the spheres and the vessels without modeling embolic effects produced
cluster-size distributions most similar to the porcine liver sample. These find-
ings have important implications for understanding liver toxicity in RE and for
refining microsphere trapping models.
6.2 Future work
This work has yielded interesting insights into the distribution of microspheres
in treated tissue and the accuracy of infusion simulations intending to repli-
cate those distributions. There are also several potential research directions
that could improve the accuracy of the simulations and increase potential ap-
plications for this work.
6.2.1 Hepatic arterial tree model
Currently, the simulated arterial tree is generated using segmentations taken
from the XCAT phantom. Simulations using segmentations taken from pa-
tient data could demonstrate the utility of these models for treatment plan-
ning; however, that would likely require the ability to model the presence of
tumors within normal tissue. The morphology of tumor vasculature is gen-
erally more complicated than normal liver vasculature, and blood flow within
those vessels is erratic, sometimes resulting in blood flowing in different di-
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rections at different times within the same vessel [22]. However, it may be
possible to approximate microsphere distributions in tumors sufficiently well
to make realistic predictions of both tumor dose and normal tissue toxicity.
In a similar vein, additional data taken to support other aspects of treat-
ment planning, such as contrast-enhanced CT or MR angiography and perfu-
sion measurements, could be used to increase the accuracy of microsphere dis-
tributions. While current work aims to allow the prediction of overall survival
and does not predict the specific dose distribution, it is possible that future
simulations could do so by incorporating more existing sources of data.
6.2.2 Micro-CT detection of glass microspheres
While the performance of glass microsphere detection and localization appeared
very good when verified using thin phantoms, larger tissue samples have higher
noise, which can result in a higher, but currently unknown, number of false
positives. During the phantom preparation process, embedding the phantoms
in larger water phantoms was discussed and rejected due to concerns that the
water could cause microspheres to shift in the agar. If the phantoms were in-
stead formed by embedding glass microspheres in tissue-equivalent resin that
was allowed to cure prior to imaging, the phantom could be submerged in dif-
ferently sized, water-filled cylinders to approximate tissue samples and verify
performance at different noise levels. Such phantoms would also avoid issues
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with microsphere shifting that was a confounding factor of the longest scans in
chapter 4.
Resin-based phantoms would also be more durable, which means they could
also be shipped to different institutions and used to measure performance of
other micro-CT scanners, allowing multi-institutional collaboration.
Higher noise levels may also require different methods to accurately detect
microspheres. With the porcine liver samples, it was necessary to use a higher
detection threshold to avoid excessive false positives, but this likely resulted
in more false negatives. If the sphere quantification stage were better able to
reject false positives, then the detection threshold could be lowered, resulting
in fewer false negatives. One aspect of the regions that is mostly ignored is
the texture. It is likely that some form of texture analysis could distinguish
spurious regions better than the simple area filter performed currently. If suf-
ficient numbers of regions were identified and labeled, neural networks could
potentially be a useful tool for quantification and false positive rejection.
6.2.3 Microsphere transport and trapping model
While the microsphere transport model that both considered diameters and
did not model embolic effects produced the most realistic cluster distributions
of the ones considered, there were still significant differences between the true
and simulated cluster distributions. For example, there were too many small
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clusters and too few large clusters. There are several potential improvements,
described below, that could produce a more realistic distribution of cluster sizes.
One is the assumption that the probability of a microsphere entering the
straighter child vessel for equal blood is 60%. While the dependence of particle
traversal on both geometry and flow is well supported in the literature, the spe-
cific branching probability of 60% was taken from a fluid dynamics simulation
that considered only two vessel generations in a single spatial arrangement.
The branching probability of other vessel arrangements has not be reported,
but it likely varies depending on both the relative angles and vessel blood flow
in a more complicated manner than was used in this work. The large number
of vessels in a full tree likely makes full fluid dynamics simulations computa-
tionally intractable, but it may be possible to perform simplified, but still more
accurate, simulations of microsphere traversal at different junctions within the
tree to produce unique branching probabilities for each type of junction.
An alternative model of particle infusion that used parameters to guide mi-
crosphere traversal was described by Högberg et al. This was specifically devel-
oped to produce cluster distributions more similar to resin microsphere cluster
distributions. While the parameters they used to guide microsphere trans-
port were not physically based, the physical parameters used in this work for
tree growth and particle transport could be adapted to produce similar effects,
though likely at the cost of some physical realism.
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A more realistic model of particle infusion could simulate the concurrent
traversal of a bolus of microspheres within the hepatic arterial tree. The pres-
ence of multiple spheres in a vessel as blood flow in the vessel decreases or stops
due to embolic effects could produce different microsphere distributions than
were observed with the models investigated in this work. This could potentially
yield more large clusters like those observed in the porcine liver sample.
Comparisons between the micro-scale dose distributions observed in the
porcine liver and the infusion simulations will also provide insight into how
much of an impact different cluster distributions have on the probability of
normal tissue toxicity. That would give a better understanding of the level of
accuracy necessary for distribution simulation to be useful.
With more detailed and personalized models of the hepatic arterial tree,
and with accurate simulations of microsphere trapping, it should be possible
to accurately predict the dose distribution in both normal and tumor tissue.
Micro-CT examination of tissue samples could also yield improvements to ra-
diobiological models describing the survival of normal liver tissue in RE. Com-
bining both improved models of microsphere distribution and RE impact could
provide a dramatic improvement in the efficacy of RE treatments and both im-
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